<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Chron Obstruct Pulmon Dis</journal-id><journal-id journal-id-type="publisher-id">International Journal of COPD</journal-id><journal-title>International Journal of Chronic Obstructive Pulmonary Disease</journal-title><issn pub-type="ppub">1176-9106</issn><issn pub-type="epub">1178-2005</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19281082</article-id><article-id pub-id-type="pmc">2650593</article-id><article-id pub-id-type="publisher-id">copd-3-671</article-id><article-categories><subj-group subj-group-type="heading"><subject>Reviews</subject></subj-group></article-categories><title-group><article-title>Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zamarr&#x000f3;n</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="af1-copd-3-671">1</xref><xref ref-type="corresp" rid="c1-copd-3-671"/></contrib><contrib contrib-type="author"><name><surname>Paz</surname><given-names>Vanesa Garc&#x000ed;a</given-names></name><xref ref-type="aff" rid="af1-copd-3-671">1</xref></contrib><contrib contrib-type="author"><name><surname>Morete</surname><given-names>Emilio</given-names></name><xref ref-type="aff" rid="af1-copd-3-671">1</xref></contrib><contrib contrib-type="author"><name><surname>del Campo Mat&#x000ed;as</surname><given-names>Felix</given-names></name><xref ref-type="aff" rid="af2-copd-3-671">2</xref></contrib></contrib-group><aff id="af1-copd-3-671"><label>1</label> Servicio de Neumolog&#x000ed;a, Hospital Cl&#x000ed;nico Universitario de Santiago, Santiago, Spain</aff><aff id="af2-copd-3-671"><label>2</label> Servicio de Neumologia, Hospital Universitario Rio Ortega de Vallaclolid, Vallaclolid, Spain</aff><author-notes><corresp id="c1-copd-3-671">Correspondence: Carlos Zamarr&#x000f3;n, Servicio de Neumolog&#x000ed;a, Hospital Cl&#x000ed;nico Universitario de Santiago, C/Travesia de la Choupana s/n 15706, Santiago de Compostela, Spain, Tel +34 9 8195 0085, Fax +34 9 8195 0454, Email<email>carlos.zamarron.sanz@sergas.es</email></corresp></author-notes><!--Dove Press titles changed from ppub to collections in 2009.								Fake epub written to satisfy Base Date Type=epub--><pub-date pub-type="ppub"><month>12</month><year>2008</year></pub-date><pub-date pub-type="epub"><month>12</month><year>2008</year></pub-date><volume>3</volume><issue>4</issue><fpage>671</fpage><lpage>682</lpage><copyright-statement>&#x000a9; 2008 Dove Medical Press Limited. All rights reserved</copyright-statement><copyright-year>2008</copyright-year><abstract><p>Obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) are two diseases that often coexist within an individual. This coexistence is known as overlap syndrome and is the result of chance rather than a pathophysiological link. Although there are claims of a very high incidence of OSAS in COPD patients, recent studies report that it is similar to the general population. Overlap patients present sleep-disordered breathing associated to upper and lower airway obstruction and a reduction in respiratory drive. These patients present unique characteristics, which set them apart from either COPD or OSAS patients. COPD and OSAS are independent risk factors for cardiovascular events and their coexistence in overlap syndrome probably increases this risk. The mechanisms underlying cardiovascular risk are still unclear, but may involve systemic inflammation, endothelial dysfunction, and tonic elevation of sympathetic neural activity. The treatment of choice for overlap syndrome in stable patients is CPAP with supplemental oxygen for correction of upper airway obstructive episodes and hypoxemia during sleep.</p></abstract><kwd-group><kwd>chronic obstructive pulmonary disease</kwd><kwd>obstructive sleep apnea syndrome</kwd><kwd>overlap syndrome</kwd><kwd>sleep</kwd><kwd>cardiovascular disease</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Chronic obstructive pulmonary disease (COPD) is a condition of progressive deterioration of the respiratory system characterized by obstruction of pulmonary airways and decreased airflow. The airflow limitation is usually progressive and associated to an abnormal inflammatory response of the lungs to noxious particles or gases, primarily caused by cigarette smoking (<xref ref-type="bibr" rid="b30-copd-3-671">Celli and MacNee 2004</xref>).</p><p>COPD consists of two disorders; chronic bronchitis and emphysema. The diagnosis of chronic bronchitis applies to patients who have a chronic productive cough for at least three months of the year in two or more successive years. On the other hand, emphysema is a pathological diagnosis describing permanent abnormal enlargement of the airspaces distal to the terminal bronchioles, accompanied by destruction of alveolar walls. Most patients have elements of both chronic bronchitis and emphysema in varying degrees, but some may have one without the other (<xref ref-type="bibr" rid="b37-copd-3-671">Clausen 1990</xref>). Although mainly affecting the lungs, it also produces other significant systemic consequences, including skeletal muscle dysfunction, nutritional abnormalities and weight loss, cardiovascular and nervous system abnormalities, as well as osteoskeletal effects (<xref ref-type="bibr" rid="b5-copd-3-671">Andreassen and Vestbo 2003</xref>; <xref ref-type="bibr" rid="b2-copd-3-671">Agusti 2005</xref>).</p><p>COPD is a major global epidemic affecting 5%&#x02013;15% of all adults in industrialized countries (<xref ref-type="bibr" rid="b122-copd-3-671">Pauwels et al 2001</xref>), normally presenting after the age of 50. Incidence increases with age, such that 50% of smokers over the age of 65 years are affected (<xref ref-type="bibr" rid="b99-copd-3-671">Louw et al 1996</xref>). Using a variety of guides, Linberg and colleagues (2005) reported a prevalence of COPD between 7.6% and 12.2%. In a multicenter epidemiological study carried out in Spain, COPD was found in 15.8% of men and 5.5% of women (<xref ref-type="bibr" rid="b124-copd-3-671">Pe&#x000f1;a et al 2000</xref>).</p><p>COPD is a major cause of morbidity, mortality, and disability in the United States. An estimated 10 million adults in this country were diagnosed with COPD in the year 2000 (<xref ref-type="bibr" rid="b96-copd-3-671">Lindstrom et al 2002</xref>). It is becoming more common, and accounts for significant and increasing utilization of health care resources (<xref ref-type="bibr" rid="b55-copd-3-671">Faulkner and Hilleman 2003</xref>; <xref ref-type="bibr" rid="b129-copd-3-671">Ramsey and Sullivan 2003</xref>).</p><p>Obstructive sleep apnea syndrome (OSAS) is a common disorder characterized by recurrent upper airway collapse during sleep (<xref ref-type="bibr" rid="b169-copd-3-671">Young et al 1993</xref>). The inspiratory efforts to overcome occlusion lead to arousal, sleep fragmentation, and oxyhemoglobin desaturation (<xref ref-type="bibr" rid="b42-copd-3-671">Deegan and McNicholas 1995</xref>). Though clinically recognized for more than two decades (<xref ref-type="bibr" rid="b65-copd-3-671">Gastaut et al 1965</xref>; <xref ref-type="bibr" rid="b100-copd-3-671">Lugaresi et al 1972</xref>; <xref ref-type="bibr" rid="b72-copd-3-671">Guilleminault 1985</xref>), general awareness of OSAS has been slow to develop. In a middle-aged population, <xref ref-type="bibr" rid="b169-copd-3-671">Young and colleagues (1993)</xref> found that 2% of women and 4% of men presented OSAS. In our community, there is an OSAS prevalence of 3.4% in men, 3% in women (<xref ref-type="bibr" rid="b48-copd-3-671">Duran et al 2001</xref>), and 6.8% among subjects 50&#x02013;70 years of age (<xref ref-type="bibr" rid="b172-copd-3-671">Zamarron et al 1999</xref>).</p><p>OSAS sometimes coexists with COPD. <xref ref-type="bibr" rid="b56-copd-3-671">Flenley (1985)</xref> called this combination &#x02018;&#x02018;overlap syndrome.&#x0201d; We analyze the epidemiology, pathophysiology, and clinical features as well as therapy for overlap syndrome.</p></sec><sec><title>Effects of sleep on ventilation</title><p>Human sleep can be divided into two patterns, nonrapid eye movement sleep (NREM) and rapid eye movement sleep (REM), each with distinctive physiological characteristics. The four stages of NREM sleep are categorized by the frequency and amplitude of the electroencephalography (EEG), the presence of sleep spindles and K complexes and electro-oculogram and electromyogram findings. REM sleep is characterized by bursts of rapid eye movement, muscle atonia and shallow and irregular breathing. REM sleep is subdivided into two periods: tonic and phasic. Longer REM periods occur mainly during the last part of nocturnal sleep.</p><p>Sleep has profound effects on ventilation (<xref ref-type="bibr" rid="b45-copd-3-671">Douglas et al 1982a</xref>), which are partly attributable to a slight decrease in metabolic rate (<xref ref-type="bibr" rid="b47-copd-3-671">Douglas 1985</xref>; <xref ref-type="bibr" rid="b158-copd-3-671">White et al 1985</xref>). In fact, the respiratory system is challenged by sleep, and for patients debilitated by respiratory disease, the conditions imposed may become excessive and lead to failure. Furthermore, when respiratory failure is already present during wakefulness, the situation is even more serious during sleep.</p><p>We will only briefly summarize the main effects of sleep on ventilation, as comprehensive descriptions already exist (<xref ref-type="bibr" rid="b125-copd-3-671">Phillipson 1978</xref>; <xref ref-type="bibr" rid="b87-copd-3-671">Krimsky and Leiter 2005</xref>).</p><p>Breathing responses are distinctly different during REM and NREM sleep. There is a significant reduction in minute ventilation, especially during REM sleep, as a result of decreased tidal volume not being fully compensated by an increase in respiratory frequency (<xref ref-type="bibr" rid="b13-copd-3-671">Becker et al 1999</xref>). The consequence is a worsening of arterial blood gases with a significant reduction in partial pressure of oxygen in arterial blood (PaO<sub>2</sub>) and an increase in partial pressure of carbon dioxide in arterial blood (PaCO<sub>2</sub>) (<xref ref-type="bibr" rid="b24-copd-3-671">Calverley et al 1982</xref>). During NREM sleep, gas exchange becomes altered with a decrease is PaO<sub>2</sub> (<xref ref-type="bibr" rid="b112-copd-3-671">Muller et al 1980</xref>), but not as much as during REM sleep.</p><p>Compared to wakefulness, ventilatory response to hypercapnia and hypoxia is diminished during NREM sleep and further depressed during REM sleep (<xref ref-type="bibr" rid="b46-copd-3-671">Douglas et al 1982b</xref>; <xref ref-type="bibr" rid="b47-copd-3-671">Douglas 1985</xref>). The ventilatory and arousal responses to hypercapnia are much more robust than for hypoxia, with only slight changes in PaCO<sub>2</sub> causing recognizable alterations of minute ventilation (<xref ref-type="bibr" rid="b111-copd-3-671">Morrell et al 1995</xref>).</p><p>Decreased muscle tone during sleep increases respiratory resistance and the inability to compensate these changes probably contributes to reduced responses (<xref ref-type="bibr" rid="b161-copd-3-671">Wiegand et al 1991</xref>). During NREM sleep, the phasic electromyographic activity of genioglossus and geniohyoid muscles is well-maintained (<xref ref-type="bibr" rid="b11-copd-3-671">Basner et al 1991</xref>), but tonic activity of upper airway dilators decreases (<xref ref-type="bibr" rid="b160-copd-3-671">Wiegand et al 1990</xref>; <xref ref-type="bibr" rid="b154-copd-3-671">Tangel et al 1992</xref>). During REM sleep, hypotonia of postural muscles, including intercostals muscles and other accessory respiratory muscles, occurs (<xref ref-type="bibr" rid="b109-copd-3-671">Millman et al 1988</xref>; <xref ref-type="bibr" rid="b163-copd-3-671">Wiegand 1990</xref>), and upper airway resistance increases (<xref ref-type="bibr" rid="b8-copd-3-671">Ballard et al 1995</xref>).</p><p>Lung volume is also reduced during sleep and this is manifested by a reduction in the functional residual capacity (FRC) during NREM sleep (<xref ref-type="bibr" rid="b79-copd-3-671">Hudgel and Devadatta 1984</xref>). Several factors, reduction in lung compliance and reduced respiratory muscle tone, have been suggested as potential causal factors in the reduction in FRC (<xref ref-type="bibr" rid="b23-copd-3-671">Bryan and Muller 1980</xref>; <xref ref-type="bibr" rid="b9-copd-3-671">Ballard et al 1990</xref>). It has been hypothesized that reduced FRC during sleep may induce the closure of airways within the regular breath, causing a ventilation&#x02013;perfusion mismatch, contributing to the small but yet significant changes in arterial saturation seen especially during REM sleep (<xref ref-type="bibr" rid="b18-copd-3-671">Block et al 1979</xref>).</p></sec><sec sec-type="subjects"><title>Effects of sleep on ventilation in COPD patients</title><p>The control of breathing in patients with COPD follows the same basic principles as in normal subjects; however, these patients present lower feedback response during sleep. A decrease in oxygen saturation during sleep may appear in normal subjects, as well as COPD patients; however, in the latter it has a much greater effects on arterial blood gases due to the different position of initial PaO<sub>2</sub> on the O<sub>2</sub> dissociation curve.</p><p>Nocturnal desaturation in COPD patients presents specific characteristics (<xref ref-type="table" rid="t1-copd-3-671">Table 1</xref>). It mainly takes place at the end of the night during REM sleep (<xref ref-type="bibr" rid="b27-copd-3-671">Catterall et al 1985</xref>) and events may vary considerably from one night to the next, especially in patients with moderate-to-severe COPD (<xref ref-type="bibr" rid="b92-copd-3-671">Lewis et al 2003</xref>). In addition, these desaturations are significantly related to daytime hypoxemia and hypercarbia (<xref ref-type="bibr" rid="b113-copd-3-671">Mulloy and McNicholas 1996</xref>); the more pronounced daytime hypoxemia and hypercapnia, the more severe nocturnal hypoxemia (<xref ref-type="bibr" rid="b56-copd-3-671">Flenley 1985</xref>). Furthermore, COPD patients may require direct assessment of nocturnal desaturation by oximetry, because the degree of hypoxemia during sleep cannot be predicted from measurement of arterial oxygen saturation in individual awake patients.</p><p>The main mechanism causing nocturnal desaturations in COPD patients is periodic hypoventilation, which, in turn, is believed to be the result of decreased activity in intercostals muscles and blunted chemical respiratory drive (<xref ref-type="bibr" rid="b155-copd-3-671">Tatsumi et al 1986</xref>; <xref ref-type="bibr" rid="b78-copd-3-671">Heijdra et al 1995</xref>). This is especially pronounced in patients with hyperinflated lung (<xref ref-type="bibr" rid="b17-copd-3-671">Berthon-Jones and Sullivan 1984</xref>). Another cause of nocturnal desaturations is the worsening of ventilation perfusion mismatching which is related to a decreased functional residual capacity and the dissociation between diaphragmatic and intercostals activity during REM sleep.</p></sec><sec sec-type="subjects"><title>Effects of sleep on ventilation in OSAS patients</title><p>During apneas caused by obstruction, the collapsed pharynx impedes airflow in spite of continued effort to breathe. This causes progressive asphyxia, which increasingly stimulates breathing efforts against the collapsed airway, typically until the person is awakened (<xref ref-type="bibr" rid="b162-copd-3-671">Wiegand and Zwillich 1994</xref>). Various factors, ranging from upper airway anatomy to central respiratory control mechanisms, interact to produce the clinical syndrome of OSAS. The primary defect is probably an anatomically small or collapsible pharyngeal airway, in combination with a sleep-induced fall in upper airway muscle activity (<xref ref-type="bibr" rid="b93-copd-3-671">Liistro 2002</xref>; <xref ref-type="bibr" rid="b61-copd-3-671">Fogel et al 2004</xref>). One or more of these variables, which conspire to cause upper airway obstruction (<xref ref-type="bibr" rid="b81-copd-3-671">Hudgel 1992</xref>; <xref ref-type="bibr" rid="b6-copd-3-671">Badr 1999</xref>), may affect any given OSAS patient.</p><p>Some studies have shown that ventilatory control is less stable in patients with OSAS, (<xref ref-type="bibr" rid="b80-copd-3-671">Hudgel et al 1998</xref>; <xref ref-type="bibr" rid="b168-copd-3-671">Younes et al 2001</xref>), while other authors claim that ventilatory instability alone is not sufficient to produce periodic breathing (<xref ref-type="bibr" rid="b157-copd-3-671">Wellman et al 2004</xref>). Upper airway resistance in OSAS appears to be influenced by the intensity of the central respiratory drive (<xref ref-type="bibr" rid="b145-copd-3-671">Series et al 1989</xref>).</p><p>Abnormal hypoxic and hypercapnic respiratory drive has also been reported in hypercapnic OSAS patients, in contrast to normal hypoxic and hypercapnic respiratory drive in eucapnic patients (<xref ref-type="bibr" rid="b64-copd-3-671">Garay et al 1981</xref>; <xref ref-type="bibr" rid="b151-copd-3-671">Soto Campos et al 1996</xref>). The role of this reduction in chemical drives is still under discussion. It is not clear whether it is an inherited abnormality in ventilatory control (<xref ref-type="bibr" rid="b51-copd-3-671">El Bayadi et al 1990</xref>; <xref ref-type="bibr" rid="b131-copd-3-671">Redline et al 1997</xref>), or secondary to sleep apnea as suggested by the improvement in ventilatory response to CO<sub>2</sub> in hypercapnic OSAS patients after CPAP therapy (<xref ref-type="bibr" rid="b16-copd-3-671">Berthon-Jones and Sullivan 1987</xref>; <xref ref-type="bibr" rid="b94-copd-3-671">Lin 1994</xref>). Lin studied six patients with hypercapnic OSAS and 24 patients with eucapnic OSAS. Both the slope and baseline level of ventilatory response and mouth occlusion pressure improved significantly in hypercapnic patients after two weeks of CPAP therapy (<xref ref-type="bibr" rid="b94-copd-3-671">Lin 1994</xref>).</p></sec><sec><title>Overlap syndrome</title><sec><title>Physiological consequences</title><p>Clinical evidence suggests that the majority of patients with OSAS are eucapnic during wakefulness, and that detection of daytime hypercapnia attests to mechanical impairment of the respiratory system due to obesity and/or COPD (<xref ref-type="bibr" rid="b71-copd-3-671">Guilleminault et al 1976</xref>; <xref ref-type="bibr" rid="b91-copd-3-671">Leech et al 1987</xref>).</p><p>Overlap syndrome predisposes to daytime hypercapnia and hypoxemia independently of lung function (<xref ref-type="bibr" rid="b33-copd-3-671">Chaouat et al 1997</xref>). Nocturnal desaturation severity is related to a specific entity within the wide spectrum of sleep-disordered breathing and the severity of COPD.</p><p>It is known that overlap patients present more nocturnal desaturation than patients with either OSAS or COPD alone (<xref ref-type="bibr" rid="b34-copd-3-671">Chaouat et al 1995</xref>; <xref ref-type="bibr" rid="b141-copd-3-671">Sanders et al 2003</xref>). <xref ref-type="bibr" rid="b141-copd-3-671">Sanders and colleagues (2003)</xref> examined the degree to which COPD and OSAS independently and jointly contribute to desaturation during sleep. After adjusting for confounding factors, the odds ratio for nocturnal oxyhemoglobin desaturation was considerably increased in OSAS patients. <xref ref-type="bibr" rid="b14-copd-3-671">Bednarek and colleagues (2005)</xref> compared polysomnographic variables between overlap syndrome and OSAS subjects. The overlap syndrome group had lower mean arterial blood saturation and spent more time in desaturation than the OSAS group. <xref ref-type="bibr" rid="b128-copd-3-671">Radwan and colleagues (1995)</xref> compared the breathing pattern and CO<sub>2</sub> response in 11 obese male overlap syndrome patients, 20 obese male OSAS patients with normal lung function, and 13 healthy nonobese controls. Overlap patients had a higher breathing frequency and lower tidal volume than OSAS patients. The OSAS group presented similar values to controls in ventilatory response to CO<sub>2</sub> and occlusion pressure responses. This author concludes that overlap patients with hypercapnia have both blunted ventilatory responses and mouth occlusion pressure responses to CO<sub>2</sub> (<xref ref-type="bibr" rid="b128-copd-3-671">Radwan et al 1995</xref>) and that ventilatory response may be disturbed by lung mechanics and gas exchange. In subjects with chronic hypercapnia, there is an increased blood bicarbonate concentration, which may inhibit CO<sub>2</sub> sensitivity and decreases mouth occlusion pressure response (<xref ref-type="bibr" rid="b128-copd-3-671">Radwan et al 1995</xref>). Other authors have postulated that hyperinflation of the lung may also decrease mouth occlusion pressure response (<xref ref-type="bibr" rid="b54-copd-3-671">Erbland et al 1990</xref>).</p><p>In patients with overlap syndrome, sleep disordered breathing is associated with upper and lower airway obstruction and a reduction in respiratory drive. Respiratory muscles may also fatigue which is related to the mechanical disadvantage of chest wall hyperinflation. Moreover, there is also a reduction in functional residual capacity which is related to supine posture and sleep state, and a ventilation perfusion mismatch (<xref ref-type="fig" rid="f1-copd-3-671">Figure 1</xref>).</p></sec><sec><title>Pulmonary hemodynamics</title><p>Pulmonary hemodynamic studies during sleep in COPD patients have been scarce probably because its invasive nature is not compatible with normal sleep (<xref ref-type="bibr" rid="b156-copd-3-671">Weitzenblum and Chaouat 2004</xref>).</p><p>Alveolar hypoxia is the most important mechanism leading to pulmonary arterial vasoconstriction and pulmonary hypertension (<xref ref-type="bibr" rid="b19-copd-3-671">Bonsignore et al 1994</xref>) and COPD is frequently complicated by the development of pulmonary hypertension, which is associated with increased morbidity and mortality (<xref ref-type="bibr" rid="b32-copd-3-671">Chaouat et al 2005</xref>; <xref ref-type="bibr" rid="b165-copd-3-671">Wright et al 2005</xref>).</p><p>OSAS patients may also present sustained pulmonary hypertension (<xref ref-type="bibr" rid="b142-copd-3-671">Sanner et al 1997</xref>; <xref ref-type="bibr" rid="b138-copd-3-671">Sajkov et al 1999</xref>; <xref ref-type="bibr" rid="b7-copd-3-671">Bady et al 2000</xref>), and the risk increases considerably if it is associated with COPD, obesity or both (<xref ref-type="bibr" rid="b20-copd-3-671">Bradley 1992</xref>; <xref ref-type="bibr" rid="b89-copd-3-671">Laks et al 1995</xref>; <xref ref-type="bibr" rid="b35-copd-3-671">Chaouat et al 1996</xref>).</p><p>In a group of patients with overlap syndrome, <xref ref-type="bibr" rid="b34-copd-3-671">Chaouat and colleagues (1995)</xref> found that the main determinants of pulmonary hypertension were daytime arterial blood gases and FEV<sub>1</sub>. In a study by <xref ref-type="bibr" rid="b76-copd-3-671">Hawrylkiewicz and colleagues (2004)</xref>, pulmonary hypertension was found in 13.6% of OSAS patients (related to disease severity and obesity) and in 80% of overlap patients.</p></sec><sec><title>Epidemiology</title><p>Overlap syndrome has a prevalence of 14% among patients with mild COPD (<xref ref-type="bibr" rid="b34-copd-3-671">Chaouat et al 1995</xref>) and 11% among patients with OSAS (<xref ref-type="bibr" rid="b141-copd-3-671">Sanders et al 2003</xref>). The prevalence of overlap syndrome is very different depending on the definition used. Some of the apparent discrepancies between studies can be explained by differences in selection criteria, population characteristics and design (<xref ref-type="table" rid="t2-copd-3-671">Table 2</xref>). In early studies, a high prevalence of OSAS was found in individuals with COPD. <xref ref-type="bibr" rid="b70-copd-3-671">Guilleminault and colleagues (1980)</xref> studied 26 COPD patients while sleeping and found that 92% of all abnormal respiratory events during sleep contained an obstructive component. <xref ref-type="bibr" rid="b34-copd-3-671">Chaouat and colleagues (1995)</xref> prospectively investigated 265 OSAS patients and reported that 11% had an obstructive spirographic pattern. <xref ref-type="bibr" rid="b133-copd-3-671">Resta and colleagues (2000)</xref> retrospectively evaluated data from 213 consecutive patients referred to the Sleep Laboratory, and found that 16% had overlap syndrome. <xref ref-type="bibr" rid="b41-copd-3-671">De Miguel and colleagues (2002)</xref> found a 28.5% prevalence of overlap in a group of patients referred to the hospital. However, this high prevalence could well be due to a selection bias. Nevertheless, a very large study including 5,954 participants done in conjunction with the Sleep Heart Health Study, did not find significant differences in the prevalence of OSAS among COPD subjects (14.0%) and those without COPD (18.6%) (<xref ref-type="bibr" rid="b141-copd-3-671">Sanders et al 2003</xref>). In the study by <xref ref-type="bibr" rid="b170-copd-3-671">Zamarron and colleagues (2003)</xref> of 300 patients referred for clinical suspicion of OSAS, 15.4% of patients were classified as overlap. More recently, <xref ref-type="bibr" rid="b14-copd-3-671">Bednarek and colleagues (2005)</xref> studied 356 males and 320 females and found overlap syndrome in 9.2% of the OSAS population, while <xref ref-type="bibr" rid="b116-copd-3-671">O&#x02019;Brien and Whitman (2005)</xref> found overlap syndrome in 11.9% of COPD patients.</p></sec></sec><sec><title>OSAS, COPD, and cardiovascular risk</title><p>Systemic inflammation is increasingly being recognized as a risk factor for a number of different complications including atherosclerosis (<xref ref-type="bibr" rid="b135-copd-3-671">Ross 1999</xref>) and is a well-established factor in the pathogenesis of cardiovascular disease (CVD) (<xref ref-type="bibr" rid="b73-copd-3-671">Hansson 2005</xref>). There is growing recognition that COPD is a systemic disease (<xref ref-type="bibr" rid="b1-copd-3-671">Agusti et al 2003</xref>; <xref ref-type="bibr" rid="b166-copd-3-671">Yende et al 2006</xref>) with multiple effects on end-organs including organs in the cardiovascular system (<xref ref-type="bibr" rid="b25-copd-3-671">Camilli et al 1991</xref>; <xref ref-type="bibr" rid="b149-copd-3-671">Sin and Man 2003</xref>). The pathophysiology of how COPD increases cardiovascular risk is largely unknown. Several studies have shown that reduced lung function is associated with an increase in a variety of systemic inflammatory markers (<xref ref-type="bibr" rid="b143-copd-3-671">Schols et al 1999</xref>; <xref ref-type="bibr" rid="b153-copd-3-671">Takabatake et al 2000</xref>; <xref ref-type="bibr" rid="b67-copd-3-671">Godoy et al 2003</xref>). <xref ref-type="bibr" rid="b63-copd-3-671">Gan and colleagues (2004)</xref> conducted a systematic review of studies involving the relationship between COPD, forced expiratory volume in one second (FEV<sub>1</sub>), and levels of various systemic inflammatory markers. Compared to healthy controls, COPD patients were found to have significantly raised levels of C-reactive protein (CRP), fibrinogen, leucocytes, and tumor necrosis factor-alpha (TNF-&#x003b1;). All of which indicate persistent systemic inflammation. This finding may explain, at least in part, the high prevalence of systemic complications (including cardiovascular diseases) among patients with COPD (<xref ref-type="bibr" rid="b63-copd-3-671">Gan et al 2004</xref>).</p><p>C-reactive protein is an important serum marker of inflammation and an independent predictor of cardiovascular disease (<xref ref-type="bibr" rid="b136-copd-3-671">Rutter et al 2004</xref>; <xref ref-type="bibr" rid="b134-copd-3-671">Ridker et al 2004</xref>). CRP is increased in COPD patients and may be a systemic marker of the inflammatory process (<xref ref-type="bibr" rid="b22-copd-3-671">Broekhuizen et al 2006</xref>; <xref ref-type="bibr" rid="b102-copd-3-671">Man et al 2006</xref>; <xref ref-type="bibr" rid="b127-copd-3-671">Pinto-Plata et al 2006</xref>).</p><p>A number of epidemiological studies have shown that OSAS is associated to cardiovascular morbidity (<xref ref-type="bibr" rid="b115-copd-3-671">Nieto et al 2000</xref>; <xref ref-type="bibr" rid="b123-copd-3-671">Peker et al 2002</xref>; <xref ref-type="bibr" rid="b12-copd-3-671">Becker et al 2003</xref>; <xref ref-type="bibr" rid="b104-copd-3-671">Marin et al 2005</xref>). In this disease, intense local and systemic inflammation occurs. These patients present elevated inflammatory mediators such as TNF-&#x003b1; and interleukin-6 (<xref ref-type="bibr" rid="b97-copd-3-671">Liu et al 2000</xref>; <xref ref-type="bibr" rid="b26-copd-3-671">Carpagnano et al 2002</xref>; <xref ref-type="bibr" rid="b82-copd-3-671">Imagawa et al 2004</xref>; <xref ref-type="bibr" rid="b68-copd-3-671">Goldbart et al 2006</xref>), leptin (<xref ref-type="bibr" rid="b83-copd-3-671">Ip et al 2000</xref>; <xref ref-type="bibr" rid="b147-copd-3-671">Shimizu et al 2002</xref>; <xref ref-type="bibr" rid="b74-copd-3-671">Harsch et al 2003</xref>; <xref ref-type="bibr" rid="b120-copd-3-671">Ozturk et al 2003</xref>; <xref ref-type="bibr" rid="b10-copd-3-671">Barcelo et al 2005</xref>), and adhesion molecules (<xref ref-type="bibr" rid="b118-copd-3-671">Ohga et al 1999</xref>; <xref ref-type="bibr" rid="b36-copd-3-671">Chin et al 2000</xref>; <xref ref-type="bibr" rid="b53-copd-3-671">El-Solh et al 2002</xref>; <xref ref-type="bibr" rid="b49-copd-3-671">Dyugovskaya et al 2002</xref>; <xref ref-type="bibr" rid="b173-copd-3-671">Zamarron-Sanz et al 2006</xref>). The levels of these mediators improve with CPAP treatment (<xref ref-type="bibr" rid="b75-copd-3-671">Hatipoglu and Rubinstein 2003</xref>; <xref ref-type="bibr" rid="b110-copd-3-671">Minoguchi et al 2004</xref>).</p><p>As in COPD, patients with OSAS present high levels of CRP, which are related to disease severity (<xref ref-type="bibr" rid="b146-copd-3-671">Shamsuzzaman et al 2002</xref>; <xref ref-type="bibr" rid="b167-copd-3-671">Yokoe et al 2003</xref>; <xref ref-type="bibr" rid="b86-copd-3-671">Kokturk et al 2005</xref>; <xref ref-type="bibr" rid="b174-copd-3-671">Zouaoui et al 2006</xref>).</p><p>Endothelial dysfunction is considered an indicator of myocardial or vascular dysfunction before the emergence of clinical signs of overt cardiovascular disease (<xref ref-type="bibr" rid="b28-copd-3-671">Celermajer et al 1992</xref>). A number of studies involving OSAS patients indicate an associated endothelial dysfunction (<xref ref-type="bibr" rid="b114-copd-3-671">Nieto et al 2004</xref>; <xref ref-type="bibr" rid="b117-copd-3-671">Oflaz et al 2006</xref>; <xref ref-type="bibr" rid="b90-copd-3-671">Lattimore et al 2006</xref>) which improved after CPAP treatment (<xref ref-type="bibr" rid="b84-copd-3-671">Ip et al 2004</xref>). Few studied, however, have focused on the relation between endothelial dysfunction and COPD. <xref ref-type="bibr" rid="b29-copd-3-671">Cella and colleagues (2001)</xref> evaluated a variety of plasma markers of endothelial dysfunction in 14 COPD patients, finding altered level of tissue factor pathway inhibitor and selectins.</p><p>Furthermore, there is evidence of a perturbed neurohumoral regulatory system in COPD patients (<xref ref-type="bibr" rid="b62-copd-3-671">Francis et al 1993</xref>; <xref ref-type="bibr" rid="b4-copd-3-671">Andreas et al 2005</xref>) and OSAS patients (<xref ref-type="bibr" rid="b150-copd-3-671">Somers et al 1988</xref>; <xref ref-type="bibr" rid="b40-copd-3-671">Cortelli et al 1994</xref>).</p><sec><title>Clinical characteristics</title><p>The most common symptoms of OSAS patients include chronic loud snoring, excessive daytime sleepiness, personality changes, and deterioration of quality of life (<xref ref-type="bibr" rid="b171-copd-3-671">Zamarron et al 1998</xref>; <xref ref-type="bibr" rid="b132-copd-3-671">Redline and Strohl 1998</xref>; <xref ref-type="bibr" rid="b126-copd-3-671">Pichel et al 2004</xref>). COPD patients, on the other hand, may present cough, sputum production, and/or dyspnea (Celli and Mcnee 2004). Nevertheless, overlap patients present unique characteristics, which set them apart from either COPD or OSAS patients.</p><p>A number of studies compare the clinical characteristics of overlap patients to those of OSAS-only patients. <xref ref-type="bibr" rid="b34-copd-3-671">Chaouat and colleagues (1995)</xref> found that, compared to the OSAS-only group, the overlap population tended to be older, with more common hypoxemia and hypercapnia, higher mean pulmonary artery pressures, but similar body mass index (BMI). <xref ref-type="bibr" rid="b116-copd-3-671">O&#x02019;Brien and Whitman (2005)</xref> found that overlap patients were older and less obese. Resta and colleagues (2002) showed that overlap patients had higher PaCO<sub>2</sub>, as well as similar apnea&#x02013;hypoapnea index (AHI). This author developed a model for predicting PaCO<sub>2</sub> in overlap patients based on PaO<sub>2</sub>, FEV<sub>1</sub>, and weight. However, overlap patients need not be distinctive in all variables. For example, studies by <xref ref-type="bibr" rid="b128-copd-3-671">Radwan and colleagues (1995)</xref> and <xref ref-type="bibr" rid="b170-copd-3-671">Zamarron and colleagues (2003)</xref> found no significant differences in OSAS severity, mean arterial oxygen saturation during sleep, and BMI.</p><p>Special notice should be taken of <xref ref-type="bibr" rid="b85-copd-3-671">Kessler&#x02019;s (1996)</xref> suggestion that in OSAS patients exhibiting permanent pulmonary hypertension, bronchial obstruction is generally not severe and the level of hypoxemia and hypercapnia is modest. Therefore, chronic airway obstruction in these patients may be asymptomatic, making it necessary to systematically perform pulmonary function tests in all patients diagnosed with OSAS by polysomnography (<xref ref-type="bibr" rid="b85-copd-3-671">Kessler et al 1996</xref>).</p></sec><sec><title>Quality of sleep</title><p>There is evidence that insomnia and other sleep problems are increased in patients with COPD (<xref ref-type="bibr" rid="b39-copd-3-671">Cormick et al 1986</xref>). Particularly in elderly COPD patients, sleep quality is decreased in the form of morning tiredness and early awakenings (<xref ref-type="bibr" rid="b15-copd-3-671">Bellia et al 2003</xref>). In addition, data from sleep studies has shown marked increases in stage changes, frequent arousals and awakenings, long sleep latency, and reduced sleep efficiency (<xref ref-type="bibr" rid="b57-copd-3-671">Fleetham et al 1982</xref>, <xref ref-type="bibr" rid="b21-copd-3-671">Brezinova et al 1982</xref>). All these sleep disturbance are likely to have multifactorial origins. Symptoms or comorbid conditions such as nocturnal cough, wheezing, depression, drugs, sedentary lifestyle, and shortness of breath may also contribute (<xref ref-type="bibr" rid="b156-copd-3-671">Weitzenblum and Chaouat 2004</xref>).</p><p>In OSAS patients, one of the most incapacitating symptoms is excessive daytime somnolence, which results from disrupted sleep or nighttime oxygen desaturation (<xref ref-type="bibr" rid="b38-copd-3-671">Colt et al 1991</xref>; <xref ref-type="bibr" rid="b144-copd-3-671">Seneviratne and Puvanendran 2004</xref>). Nevertheless, COPD patients did not have any significant daytime sleepiness, despite feeling somewhat tired (<xref ref-type="bibr" rid="b119-copd-3-671">Orr et al 1990</xref>; <xref ref-type="bibr" rid="b137-copd-3-671">Saaresranta et al 2005</xref>).</p><p><xref ref-type="bibr" rid="b141-copd-3-671">Sanders and colleagues (2003)</xref> have observed that COPD-only patients had minimally perturbed sleep. No significant differences were observed in sleep structure with respect to FEV<sub>1</sub>. <xref ref-type="bibr" rid="b130-copd-3-671">Redline and colleagues (2004)</xref>, in a community-based study, showed that sleep structure variables did not change in subjects with a history of lung disease. In addition, they found that sleep stage distributions varied in accordance with AHI level.</p><p>Poor-quality sleep may also be associated to hypoxemia and increased superficial sleep (<xref ref-type="bibr" rid="b140-copd-3-671">Sandek et al 1999</xref>).</p></sec><sec><title>Diagnostic procedures</title><p>The diagnosis of OSAS should be based on clinical findings and confirmed by a full-night polysomnography, which has traditionally been regarded as the gold standard for diagnosis (<xref ref-type="bibr" rid="b43-copd-3-671">Deegan and McNicholas 1996</xref>; <xref ref-type="bibr" rid="b59-copd-3-671">Flemons 2002</xref>; <xref ref-type="bibr" rid="b88-copd-3-671">Kushida et al 2005</xref>). However, alternatives that are less expensive and time consuming are increasingly becoming popular (<xref ref-type="bibr" rid="b58-copd-3-671">Flemons et al 2004</xref>; <xref ref-type="bibr" rid="b159-copd-3-671">Whitelaw et al 2005</xref>) (<xref ref-type="fig" rid="f2-copd-3-671">Figure 2</xref>).</p><p>With respect to COPD, clinical assessment should include questions about sleep quality and possible co-existing OSAS. Polysomnography studies are not indicated in COPD except in special circumstances which include a clinical suspicion of OSAS (hypersomnolence), nocturnal hypoxemia complications unexplained by waking arterial oxygen levels, and pulmonary hypertension that is out of proportion to the severity of pulmonary function derangement (<xref ref-type="bibr" rid="b44-copd-3-671">Douglas and Flenley 1990</xref>).</p></sec></sec><sec><title>Treatment</title><p>All patients with OSAS should be counseled about the potential benefits of therapy and the risks of going without therapy. Furthermore, they should be advised of the importance of avoiding factors that increase the severity of upper-airway obstruction such as sleep deprivation, the use of alcohol, hypnotic agents, and increased weight (<xref ref-type="bibr" rid="b98-copd-3-671">Loube et al 1994</xref>; <xref ref-type="bibr" rid="b77-copd-3-671">Haynes 2005</xref>). Although CPAP therapy is a well-established, widely used treatment, it is not suitable for all patients (<xref ref-type="bibr" rid="b121-copd-3-671">Patel et al 2003</xref>; <xref ref-type="bibr" rid="b105-copd-3-671">Marshall et al 2006</xref>; <xref ref-type="bibr" rid="b66-copd-3-671">Giles et al 2006</xref>).</p><p>Conventional O<sub>2</sub> therapy is prescribed to stable COPD patients who exhibit marked and persistent hypoxemia. This therapy is sufficient for correcting even severe nocturnal desaturation and has favorable effects on the observed hypoxemia related peaks of pulmonary hypertension (<xref ref-type="bibr" rid="b60-copd-3-671">Fletcher and Levin 1984</xref>). Some authors report that oxygen therapy improves the quality of sleep by shortening latency to sleep, increasing REM sleep as well as stages 3 and 4, and by decreasing number of arousals (<xref ref-type="bibr" rid="b69-copd-3-671">Goldstein et al 1984</xref>, <xref ref-type="bibr" rid="b24-copd-3-671">Calverley et al 1982</xref>). However, discrepant results exists (<xref ref-type="bibr" rid="b57-copd-3-671">Fleetham et al 1982</xref>; <xref ref-type="bibr" rid="b107-copd-3-671">McKeon et al 1989</xref>), which may be due to differences in the severities of daytime and nighttime hypoxemia, as well as study design.</p><p>In some patients, particularly those with hypercapnia, higher oxygen flows may induce further carbon dioxide retention with resultant morning headache and confusion. However, if there is a marked worsening in hypercapnia with oxygen therapy, noninvasive nocturnal ventilation (NIPPV) may be added. Although the precise mechanisms are not yet clear, NIPPV could improve gas exchange in COPD patients by resting the respiratory muscles, resetting the respiratory centers (<xref ref-type="bibr" rid="b52-copd-3-671">Elliott et al 1991</xref>) and improving respiratory mechanics (<xref ref-type="bibr" rid="b148-copd-3-671">Simonds et al 1989</xref>). Nevertheless, there are conflicting results regarding the utility of this treatment in long-term COPD, particularly during sleep (<xref ref-type="bibr" rid="b164-copd-3-671">Wijkstra et al 2003</xref>; <xref ref-type="bibr" rid="b3-copd-3-671">Ambrosino and Strambi 2004</xref>).</p><p>Additional treatment options include theophylline, ipratropium bromide tiotropium (<xref ref-type="bibr" rid="b101-copd-3-671">Man et al 1996</xref>; <xref ref-type="bibr" rid="b106-copd-3-671">Martin et al 1999</xref>; <xref ref-type="bibr" rid="b108-copd-3-671">McNicholas et al 2004</xref>).</p><p>Certain drugs should be administered with caution. Hypnotics, for example, can adversely affect respiration and gas exchange in patients with COPD by decreasing upper airway muscle tone and blunting the respiratory drive (<xref ref-type="bibr" rid="b152-copd-3-671">Steens et al 1993</xref>). It is also advisable for COPD patients to avoid alcohol ingestion before sleep because it has been shown to worsen hypoxemia (<xref ref-type="bibr" rid="b50-copd-3-671">Easton et al 1987</xref>) or lead to hypercapnic respiratory failure (<xref ref-type="bibr" rid="b31-copd-3-671">Chan et al 1990</xref>).</p><p>The coexistence of OSAS and COPD defines a group of special risk patients. In these overlap patients, waking and sleep-related hypoxemia and hypoxemic cardiovascular consequences are more marked than in OSAS-only patients.</p><p>CPAP has been shown to acutely improve overnight oxygenation in patients with overlap syndrome. In fact, CPAP with supplemental oxygen for correction of upper airway obstructive episodes and hypoxemia during sleep is the treatment of choice for these patients (<xref ref-type="bibr" rid="b139-copd-3-671">Sampol et al 1996</xref>).</p><p>Few studies exist on the long-term effect of CPAP in overlap syndrome. <xref ref-type="bibr" rid="b41-copd-3-671">De Miguel and colleagues (2002)</xref> evaluated the effects of CPAP therapy on lung function in patients with overlap syndrome over two consecutive years. After six months of CPAP therapy, there were statistically significant increases in PaO<sub>2</sub>, FEV<sub>1</sub>, and forced vital capacity (FVC). Response of overlap syndrome patients to CPAP therapy was superior in the hypercapnic group, particularly in relation to improvement of arterial blood gases.</p><p><xref ref-type="bibr" rid="b103-copd-3-671">Mansfield and Naughton (1999)</xref> evaluated the effects of CPAP on lung function in patients with overlap. Fourteen patients were studied, ten of whom were able to tolerate CPAP for at least three months. Improvement was found in gas exchange and FEV<sub>1</sub> associated with a decrease in hospitalizations.</p><p>CPAP treatment may have other potentially benefits. As COPD is an inflammatory airways disorder, it may be that OSAS acts as an inflammatory stimulus. Thus, the improvement in OSAS resulting from the application of CPAP may, in turn, lead to an improvement in the coexistent COPD. Nevertheless, further study is still needed.</p></sec></body><back><ack><title>Acknowledgments</title><p>Funding for this study was provided by grants PGIDIT04SIN206003PR and FIS PI051094. The authors report no conflicts of interest in this work.</p></ack><ref-list><title>References</title><ref id="b1-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Agusti</surname><given-names>AG</given-names></name><name><surname>Noguera</surname><given-names>A</given-names></name><name><surname>Sauleda</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>Systemic effects of chronic obstructive pulmonary disease</article-title><source>Eur Respir J</source><volume>21</volume><fpage>347</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">12608452</pub-id></citation></ref><ref id="b2-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Agusti</surname><given-names>AG</given-names></name></person-group><year>2005</year><article-title>COPD, a multicomponent disease: implications for management</article-title><source>Respir Med</source><volume>99</volume><fpage>670</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">15878483</pub-id></citation></ref><ref id="b3-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ambrosino</surname><given-names>N</given-names></name><name><surname>Strambi</surname><given-names>S</given-names></name></person-group><year>2004</year><article-title>New strategies to improve exercise tolerance in chronic obstructive pulmonary disease</article-title><source>Eur Respir J</source><volume>24</volume><fpage>313</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15332404</pub-id></citation></ref><ref id="b4-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andreas</surname><given-names>S</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Scanlon</surname><given-names>PD</given-names></name><etal/></person-group><year>2005</year><article-title>Neurohumoral activation as a link to systemic manifestations of chronic lung disease</article-title><source>Chest</source><volume>128</volume><fpage>3618</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">16304321</pub-id></citation></ref><ref id="b5-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andreassen</surname><given-names>H</given-names></name><name><surname>Vestbo</surname><given-names>J</given-names></name></person-group><year>2003</year><article-title>Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective</article-title><source>Eur Respir J Suppl</source><volume>46</volume><fpage>2</fpage><lpage>4</lpage></citation></ref><ref id="b6-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Badr</surname><given-names>MS</given-names></name></person-group><year>1999</year><article-title>Pathogenesis of obstructive sleep apnea</article-title><source>Prog Cardiovasc Dis</source><volume>41</volume><fpage>323</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">10406326</pub-id></citation></ref><ref id="b7-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bady</surname><given-names>E</given-names></name><name><surname>Achkar</surname><given-names>A</given-names></name><name><surname>Pascal</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>Pulmonary arterial hypertension in patients with sleep apnoea syndrome</article-title><source>Thorax</source><volume>55</volume><fpage>934</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11050263</pub-id></citation></ref><ref id="b8-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballard</surname><given-names>RD</given-names></name><name><surname>Clover</surname><given-names>CW</given-names></name><name><surname>Suh</surname><given-names>BY</given-names></name></person-group><year>1995</year><article-title>Influence of sleep on respiratory function in emphysema</article-title><source>Am J Respir Crit Care Med</source><volume>151</volume><fpage>945</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">7697271</pub-id></citation></ref><ref id="b9-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ballard</surname><given-names>RD</given-names></name><name><surname>Irvin</surname><given-names>CG</given-names></name><name><surname>Martin</surname><given-names>RJ</given-names></name><etal/></person-group><year>1990</year><article-title>Influence of sleep on lung volume in asthmatic patients and normal subjects</article-title><source>J Appl Physiol</source><volume>68</volume><fpage>2034</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">2361905</pub-id></citation></ref><ref id="b10-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barcelo</surname><given-names>A</given-names></name><name><surname>Barbe</surname><given-names>F</given-names></name><name><surname>Llompart</surname><given-names>E</given-names></name><etal/></person-group><year>2005</year><article-title>Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity</article-title><source>Am J Respir Crit Care Med</source><volume>171</volume><fpage>183</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15516536</pub-id></citation></ref><ref id="b11-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basner</surname><given-names>RC</given-names></name><name><surname>Ringler</surname><given-names>J</given-names></name><name><surname>Schwartzstein</surname><given-names>RM</given-names></name><etal/></person-group><year>1991</year><article-title>Phasic electro-myographic activity of the genioglossus increases in normals during slow-wave sleep</article-title><source>Respir Physiol</source><volume>83</volume><fpage>189</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">2068416</pub-id></citation></ref><ref id="b12-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>HF</given-names></name><name><surname>Jerrentrup</surname><given-names>A</given-names></name><name><surname>Ploch</surname><given-names>T</given-names></name><etal/></person-group><year>2003</year><article-title>Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea</article-title><source>Circulation</source><volume>107</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">12515745</pub-id></citation></ref><ref id="b13-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>HF</given-names></name><name><surname>Piper</surname><given-names>AJ</given-names></name><name><surname>Flynn</surname><given-names>WE</given-names></name><etal/></person-group><year>1999</year><article-title>Breathing during sleep in patients with nocturnal desaturation</article-title><source>Am J Respir Crit Care Med</source><volume>159</volume><fpage>112</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9872827</pub-id></citation></ref><ref id="b14-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bednarek</surname><given-names>M</given-names></name><name><surname>Plywaczewski</surname><given-names>R</given-names></name><name><surname>Jonczak</surname><given-names>L</given-names></name><etal/></person-group><year>2005</year><article-title>There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study</article-title><source>Respiration</source><volume>72</volume><fpage>142</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15824523</pub-id></citation></ref><ref id="b15-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellia</surname><given-names>V</given-names></name><name><surname>Catalano</surname><given-names>F</given-names></name><name><surname>Scichilone</surname><given-names>N</given-names></name><etal/></person-group><year>2003</year><article-title>Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study</article-title><source>Sleep</source><volume>26</volume><fpage>318</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">12749552</pub-id></citation></ref><ref id="b16-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berthon-Jones</surname><given-names>M</given-names></name><name><surname>Sullivan</surname><given-names>CE</given-names></name></person-group><year>1987</year><article-title>Time course of change in ventilatory response to CO<sub>2</sub> with long-term CPAP therapy for obstructive sleep apnea</article-title><source>Am Rev Respir Dis</source><volume>135</volume><fpage>144</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3099616</pub-id></citation></ref><ref id="b17-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berthon-Jones</surname><given-names>M</given-names></name><name><surname>Sullivan</surname><given-names>CE</given-names></name></person-group><year>1984</year><article-title>Ventilation and arousal responses to hypercapnia in normal sleeping humans</article-title><source>J Appl Physiol</source><volume>57</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">6432751</pub-id></citation></ref><ref id="b18-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Block</surname><given-names>AJ</given-names></name><name><surname>Boysen</surname><given-names>PG</given-names></name><name><surname>Wynne</surname><given-names>JW</given-names></name><etal/></person-group><year>1979</year><article-title>Sleep apnea, hypopnea and oxygen desaturation in normal subjects. A strong male predominance</article-title><source>N Engl J Med</source><volume>300</volume><fpage>513</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">216912</pub-id></citation></ref><ref id="b19-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonsignore</surname><given-names>MR</given-names></name><name><surname>Marrone</surname><given-names>O</given-names></name><name><surname>Insalaco</surname><given-names>G</given-names></name><etal/></person-group><year>1994</year><article-title>The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms</article-title><source>Eur Respir J</source><volume>7</volume><fpage>786</fpage><lpage>805</lpage><pub-id pub-id-type="pmid">8005263</pub-id></citation></ref><ref id="b20-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>TD</given-names></name></person-group><year>1992</year><article-title>Right and left ventricular functional impairment and sleep apnea</article-title><source>Clin Chest Med</source><volume>13</volume><fpage>459</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">1521413</pub-id></citation></ref><ref id="b21-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brezinova</surname><given-names>V</given-names></name><name><surname>Catterall</surname><given-names>JR</given-names></name><name><surname>Douglas</surname><given-names>NJ</given-names></name><etal/></person-group><year>1982</year><article-title>Night sleep of patients with chronic ventilatory failure and age matched controls: number and duration of the EEG episodes of intervening wakefulness and drowsiness</article-title><source>Sleep</source><volume>5</volume><fpage>123</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">7100743</pub-id></citation></ref><ref id="b22-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broekhuizen</surname><given-names>R</given-names></name><name><surname>Wouters</surname><given-names>EF</given-names></name><name><surname>Creutzberg</surname><given-names>EC</given-names></name><etal/></person-group><year>2006</year><article-title>Raised CRP levels mark metabolic and functional impairment in advanced COPD</article-title><source>Thorax</source><volume>61</volume><fpage>17</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">16055618</pub-id></citation></ref><ref id="b23-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bryan</surname><given-names>AC</given-names></name><name><surname>Muller</surname><given-names>NL</given-names></name></person-group><year>1980</year><article-title>Lung mechanics and gas exchange during sleep</article-title><source>Sleep</source><volume>3</volume><fpage>401</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7194498</pub-id></citation></ref><ref id="b24-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calverley</surname><given-names>PM</given-names></name><name><surname>Brezinova</surname><given-names>V</given-names></name><name><surname>Douglas</surname><given-names>NJ</given-names></name><etal/></person-group><year>1982</year><article-title>The effect of oxygenation on sleep quality in chronic bronchitis and emphysema</article-title><source>Am Rev Respir Dis</source><volume>126</volume><fpage>206</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">7103244</pub-id></citation></ref><ref id="b25-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camilli</surname><given-names>AE</given-names></name><name><surname>Robbins</surname><given-names>DR</given-names></name><name><surname>Lebowitz</surname><given-names>MD</given-names></name></person-group><year>1991</year><article-title>Death certificate reporting of confirmed airways obstructive disease</article-title><source>Am J Epidemiol</source><volume>133</volume><fpage>795</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">2021146</pub-id></citation></ref><ref id="b26-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carpagnano</surname><given-names>GE</given-names></name><name><surname>Kharitonov</surname><given-names>SA</given-names></name><name><surname>Resta</surname><given-names>O</given-names></name><etal/></person-group><year>2002</year><article-title>Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients</article-title><source>Chest</source><volume>122</volume><fpage>1162</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12377837</pub-id></citation></ref><ref id="b27-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>JR</given-names></name><name><surname>Calverley</surname><given-names>PM</given-names></name><name><surname>MacNee</surname><given-names>W</given-names></name><etal/></person-group><year>1985</year><article-title>Mechanism of transient nocturnal hypoxemia in hypoxic chronic bronchitis and emphysema</article-title><source>J Appl Physiol</source><volume>59</volume><fpage>1698</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">4077777</pub-id></citation></ref><ref id="b28-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Celermajer</surname><given-names>DS</given-names></name><name><surname>Sorensen</surname><given-names>KE</given-names></name><name><surname>Gooch</surname><given-names>VM</given-names></name><etal/></person-group><year>1992</year><article-title>Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis</article-title><source>Lancet</source><volume>340</volume><fpage>1111</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">1359209</pub-id></citation></ref><ref id="b29-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cella</surname><given-names>G</given-names></name><name><surname>Sbarai</surname><given-names>A</given-names></name><name><surname>Mazzaro</surname><given-names>G</given-names></name><etal/></person-group><year>2001</year><article-title>Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease</article-title><source>Clin Appl Thromb Hemost</source><volume>7</volume><fpage>205</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11441980</pub-id></citation></ref><ref id="b30-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Celli</surname><given-names>BR</given-names></name><name><surname>MacNee</surname><given-names>W</given-names></name></person-group><year>2004</year><article-title>Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper</article-title><source>Eur Respir J</source><volume>23</volume><fpage>932</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">15219010</pub-id></citation></ref><ref id="b31-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>CS</given-names></name><name><surname>Bye</surname><given-names>PT</given-names></name><name><surname>Woolcock</surname><given-names>AJ</given-names></name><etal/></person-group><year>1990</year><article-title>Eucapnia and hypercapnia in patients with chronic airflow limitation. The role of the upper airway</article-title><source>Am Rev Respir Dis</source><volume>141</volume><fpage>861</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">2109557</pub-id></citation></ref><ref id="b32-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaouat</surname><given-names>A</given-names></name><name><surname>Bugnet</surname><given-names>AS</given-names></name><name><surname>Kadaoui</surname><given-names>N</given-names></name><etal/></person-group><year>2005</year><article-title>Severe pulmonary hypertension and chronic obstructive pulmonary disease</article-title><source>Am J Respir Crit Care Med</source><volume>172</volume><fpage>189</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">15831842</pub-id></citation></ref><ref id="b33-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaouat</surname><given-names>A</given-names></name><name><surname>Weitzenblum</surname><given-names>E</given-names></name><name><surname>Kessler</surname><given-names>R</given-names></name><etal/></person-group><year>1997</year><article-title>Sleep-related O<sub>2</sub> desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia</article-title><source>Eur Respir J</source><volume>10</volume><fpage>1730</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9272911</pub-id></citation></ref><ref id="b34-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaouat</surname><given-names>A</given-names></name><name><surname>Weitzenblum</surname><given-names>E</given-names></name><name><surname>Krieger</surname><given-names>J</given-names></name><etal/></person-group><year>1995</year><article-title>Association of chronic obstructive pulmonary disease and sleep apnea syndrome</article-title><source>Am J Respir Crit Care Med</source><volume>151</volume><fpage>82</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7812577</pub-id></citation></ref><ref id="b35-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaouat</surname><given-names>A</given-names></name><name><surname>Weitzenblum</surname><given-names>E</given-names></name><name><surname>Krieger</surname><given-names>J</given-names></name><etal/></person-group><year>1996</year><article-title>Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients</article-title><source>Chest</source><volume>109</volume><fpage>380</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8620709</pub-id></citation></ref><ref id="b36-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><etal/></person-group><year>2000</year><article-title>Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome</article-title><source>Am J Med</source><volume>109</volume><fpage>562</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11063958</pub-id></citation></ref><ref id="b37-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clausen</surname><given-names>JL</given-names></name></person-group><year>1990</year><article-title>The diagnosis of emphysema, chronic bronchitis, and asthma</article-title><source>Clin Chest Med</source><volume>11</volume><fpage>405</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">2205439</pub-id></citation></ref><ref id="b38-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colt</surname><given-names>HG</given-names></name><name><surname>Haas</surname><given-names>H</given-names></name><name><surname>Rich</surname><given-names>GB</given-names></name></person-group><year>1991</year><article-title>Hypoxemia vs sleep fragmentation as cause of excessive daytime sleepiness in obstructive sleep apnea</article-title><source>Chest</source><volume>100</volume><fpage>1542</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1959392</pub-id></citation></ref><ref id="b39-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cormick</surname><given-names>W</given-names></name><name><surname>Olson</surname><given-names>LG</given-names></name><name><surname>Hensley</surname><given-names>MJ</given-names></name><etal/></person-group><year>1986</year><article-title>Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease</article-title><source>Thorax</source><volume>41</volume><fpage>846</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">3824271</pub-id></citation></ref><ref id="b40-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cortelli</surname><given-names>P</given-names></name><name><surname>Parchi</surname><given-names>P</given-names></name><name><surname>Sforza</surname><given-names>E</given-names></name><etal/></person-group><year>1994</year><article-title>Cardiovascular autonomic dysfunction in normotensive awake subjects with obstructive sleep apnoea syndrome</article-title><source>Clin Auton Res</source><volume>4</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">8054838</pub-id></citation></ref><ref id="b41-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Miguel</surname><given-names>J</given-names></name><name><surname>Cabello</surname><given-names>J</given-names></name><name><surname>Sanchez-Alarcos</surname><given-names>JM</given-names></name><etal/></person-group><year>2002</year><article-title>Long-term effects of treatment with nasal continuous positive airway pressure on lung function in patients with overlap syndrome</article-title><source>Sleep Breath</source><volume>6</volume><fpage>3</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">11917258</pub-id></citation></ref><ref id="b42-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deegan</surname><given-names>PC</given-names></name><name><surname>McNicholas</surname><given-names>WT</given-names></name></person-group><year>1995</year><article-title>Pathophysiology of obstructive sleep apnoea</article-title><source>Eur Respir J</source><volume>8</volume><fpage>1161</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">7589402</pub-id></citation></ref><ref id="b43-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deegan</surname><given-names>PC</given-names></name><name><surname>McNicholas</surname><given-names>WT</given-names></name></person-group><year>1996</year><article-title>Predictive value of clinical features for the obstructive sleep apnoea syndrome</article-title><source>Eur Respir J</source><volume>9</volume><fpage>117</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">8834344</pub-id></citation></ref><ref id="b44-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>NJ</given-names></name><name><surname>Flenley</surname><given-names>DC</given-names></name></person-group><year>1990</year><article-title>Breathing during sleep in patients with obstructive lung disease</article-title><source>Am Rev Respir Dis</source><volume>141</volume><fpage>1055</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">2183654</pub-id></citation></ref><ref id="b45-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>NJ</given-names></name><name><surname>White</surname><given-names>DP</given-names></name><name><surname>Pickett</surname><given-names>CK</given-names></name><etal/></person-group><year>1982a</year><article-title>Respiration during sleep in normal man</article-title><source>Thorax</source><volume>37</volume><fpage>840</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">7164002</pub-id></citation></ref><ref id="b46-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>NJ</given-names></name><name><surname>White</surname><given-names>DP</given-names></name><name><surname>Weil</surname><given-names>JV</given-names></name><etal/></person-group><year>1982b</year><article-title>Hypercapnic ventilatory response in sleeping adults</article-title><source>Am Rev Respir Dis</source><volume>126</volume><fpage>758</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">7149440</pub-id></citation></ref><ref id="b47-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>NJ</given-names></name></person-group><year>1985</year><article-title>Control of ventilation during sleep</article-title><source>Clin Chest Med</source><volume>6</volume><fpage>563</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">3853477</pub-id></citation></ref><ref id="b48-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duran</surname><given-names>J</given-names></name><name><surname>Esnaola</surname><given-names>S</given-names></name><name><surname>Rubio</surname><given-names>R</given-names></name><etal/></person-group><year>2001</year><article-title>Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr</article-title><source>Am J Respir Crit Care Med</source><volume>163</volume><fpage>685</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11254524</pub-id></citation></ref><ref id="b49-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dyugovskaya</surname><given-names>L</given-names></name><name><surname>Lavie</surname><given-names>P</given-names></name><name><surname>Lavie</surname><given-names>L</given-names></name></person-group><year>2002</year><article-title>Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients</article-title><source>Am J Respir Crit Care Med</source><volume>165</volume><fpage>934</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11934717</pub-id></citation></ref><ref id="b50-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Easton</surname><given-names>PA</given-names></name><name><surname>West</surname><given-names>P</given-names></name><name><surname>Meatherall</surname><given-names>RC</given-names></name><etal/></person-group><year>1987</year><article-title>The effect of excessive ethanol ingestion on sleep in severe chronic obstructive pulmonary disease</article-title><source>Sleep</source><volume>10</volume><fpage>224</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">3629084</pub-id></citation></ref><ref id="b51-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El Bayadi</surname><given-names>S</given-names></name><name><surname>Millman</surname><given-names>RP</given-names></name><name><surname>Tishler</surname><given-names>PV</given-names></name><etal/></person-group><year>1990</year><article-title>A family study of sleep apnea. Anatomic and physiologic interactions</article-title><source>Chest</source><volume>98</volume><fpage>554</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2394135</pub-id></citation></ref><ref id="b52-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>MW</given-names></name><name><surname>Mulvey</surname><given-names>DA</given-names></name><name><surname>Moxham</surname><given-names>J</given-names></name><etal/></person-group><year>1991</year><article-title>Domiciliary nocturnal nasal intermittent positive pressure ventilation in COPD: mechanisms underlying changes in arterial blood gas tensions</article-title><source>Eur Respir J</source><volume>4</volume><fpage>1044</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">1756837</pub-id></citation></ref><ref id="b53-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Solh</surname><given-names>AA</given-names></name><name><surname>Mador</surname><given-names>MJ</given-names></name><name><surname>Sikka</surname><given-names>P</given-names></name><etal/></person-group><year>2002</year><article-title>Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea</article-title><source>Chest</source><volume>121</volume><fpage>1541</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12006441</pub-id></citation></ref><ref id="b54-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erbland</surname><given-names>ML</given-names></name><name><surname>Ebert</surname><given-names>RV</given-names></name><name><surname>Snow</surname><given-names>SL</given-names></name></person-group><year>1990</year><article-title>Interaction of hypoxia and hypercapnia on respiratory drive in patients with COPD</article-title><source>Chest</source><volume>97</volume><fpage>1289</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">2347212</pub-id></citation></ref><ref id="b55-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faulkner</surname><given-names>MA</given-names></name><name><surname>Hilleman</surname><given-names>DE</given-names></name></person-group><year>2003</year><article-title>Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future</article-title><source>Pharmacotherapy</source><volume>23</volume><fpage>1300</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">14594347</pub-id></citation></ref><ref id="b56-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flenley</surname><given-names>DC</given-names></name></person-group><year>1985</year><article-title>Sleep in chronic obstructive lung disease</article-title><source>Clin Chest Med</source><volume>6</volume><fpage>651</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">2935359</pub-id></citation></ref><ref id="b57-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fleetham</surname><given-names>J</given-names></name><name><surname>West</surname><given-names>P</given-names></name><name><surname>Mezon</surname><given-names>B</given-names></name><etal/></person-group><year>1982</year><article-title>Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy</article-title><source>Am Rev Respir Dis</source><volume>126</volume><fpage>429</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">7125332</pub-id></citation></ref><ref id="b58-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flemons</surname><given-names>WW</given-names></name><name><surname>Douglas</surname><given-names>NJ</given-names></name><name><surname>Kuna</surname><given-names>ST</given-names></name><etal/></person-group><year>2004</year><article-title>Access to diagnosis and treatment of patients with suspected sleep apnea</article-title><source>Am J Respir Crit Care Med</source><volume>169</volume><fpage>668</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">15003950</pub-id></citation></ref><ref id="b59-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flemons</surname><given-names>WW</given-names></name></person-group><year>2002</year><article-title>Clinical practice. Obstructive sleep apnea</article-title><source>N Engl J Med</source><volume>347</volume><fpage>498</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">12181405</pub-id></citation></ref><ref id="b60-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>EC</given-names></name><name><surname>Levin</surname><given-names>DC</given-names></name></person-group><year>1984</year><article-title>Cardiopulmonary hemodynamics during sleep in subjects with chronic obstructive pulmonary disease. The effect of short- and long-term oxygen</article-title><source>Chest</source><volume>85</volume><fpage>6</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">6690253</pub-id></citation></ref><ref id="b61-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fogel</surname><given-names>RB</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>DP</given-names></name></person-group><year>2004</year><article-title>Sleep. 2: pathophysiology of obstructive sleep apnoea/hypopnoea syndrome</article-title><source>Thorax</source><volume>59</volume><fpage>159</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">14760159</pub-id></citation></ref><ref id="b62-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>GS</given-names></name><name><surname>McDonald</surname><given-names>KM</given-names></name><name><surname>Cohn</surname><given-names>JN</given-names></name></person-group><year>1993</year><article-title>Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention</article-title><source>Circulation</source><volume>87</volume><fpage>90</fpage><lpage>6</lpage></citation></ref><ref id="b63-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>WQ</given-names></name><name><surname>Man</surname><given-names>SF</given-names></name><name><surname>Senthilselvan</surname><given-names>A</given-names></name><etal/></person-group><year>2004</year><article-title>Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis</article-title><source>Thorax</source><volume>59</volume><fpage>574</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">15223864</pub-id></citation></ref><ref id="b64-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garay</surname><given-names>SM</given-names></name><name><surname>Rapoport</surname><given-names>D</given-names></name><name><surname>Sorkin</surname><given-names>B</given-names></name><etal/></person-group><year>1981</year><article-title>Regulation of ventilation in the obstructive sleep apnea syndrome</article-title><source>Am Rev Respir Dis</source><volume>124</volume><fpage>451</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">7294507</pub-id></citation></ref><ref id="b65-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gastaut</surname><given-names>H</given-names></name><name><surname>Tassinari</surname><given-names>CA</given-names></name><name><surname>Duron</surname><given-names>B</given-names></name></person-group><year>1965</year><article-title>Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome</article-title><source>Rev Neurol (Paris)</source><volume>112</volume><fpage>568</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">5856212</pub-id></citation></ref><ref id="b66-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giles</surname><given-names>TL</given-names></name><name><surname>Lasserson</surname><given-names>TJ</given-names></name><name><surname>Smith</surname><given-names>BJ</given-names></name><etal/></person-group><year>2006</year><article-title>Continuous positive airways pressure for obstructive sleep apnoea in adults</article-title><source>Cochrane Database Syst Rev</source><fpage>CD001106</fpage></citation></ref><ref id="b67-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Godoy</surname><given-names>I</given-names></name><name><surname>Campana</surname><given-names>AO</given-names></name><name><surname>Geraldo</surname><given-names>RR</given-names></name><etal/></person-group><year>2003</year><article-title>Cytokines and dietary energy restriction in stable chronic obstructive pulmonary disease patients</article-title><source>Eur Respir J</source><volume>22</volume><fpage>920</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">14680079</pub-id></citation></ref><ref id="b68-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldbart</surname><given-names>AD</given-names></name><name><surname>Krishna</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>RC</given-names></name><etal/></person-group><year>2006</year><article-title>Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome</article-title><source>Chest</source><volume>130</volume><fpage>143</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16840394</pub-id></citation></ref><ref id="b69-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>RS</given-names></name><name><surname>Ramcharan</surname><given-names>V</given-names></name><name><surname>Bowes</surname><given-names>G</given-names></name><etal/></person-group><year>1984</year><article-title>Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease</article-title><source>N Engl J Med</source><volume>310</volume><fpage>425</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">6420700</pub-id></citation></ref><ref id="b70-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guilleminault</surname><given-names>C</given-names></name><name><surname>Cummiskey</surname><given-names>J</given-names></name><name><surname>Motta</surname><given-names>J</given-names></name></person-group><year>1980</year><article-title>Chronic obstructive airflow disease and sleep studies</article-title><source>Am Rev Respir Dis</source><volume>122</volume><fpage>397</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">7416615</pub-id></citation></ref><ref id="b71-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guilleminault</surname><given-names>C</given-names></name><name><surname>Tilkian</surname><given-names>A</given-names></name><name><surname>Dement</surname><given-names>WC</given-names></name></person-group><year>1976</year><article-title>The sleep apnea syndromes</article-title><source>Ann Rev Med</source><volume>27</volume><fpage>465</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">180875</pub-id></citation></ref><ref id="b72-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guilleminault</surname><given-names>C</given-names></name></person-group><year>1985</year><article-title>Obstructive sleep apnea. The clinical syndrome and historical perspective</article-title><source>Med Clin North Am</source><volume>69</volume><fpage>1187</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">3906300</pub-id></citation></ref><ref id="b73-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>GK</given-names></name></person-group><year>2005</year><article-title>Inflammation, atherosclerosis, and coronary artery disease</article-title><source>N Engl J Med</source><volume>352</volume><fpage>1685</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">15843671</pub-id></citation></ref><ref id="b74-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harsch</surname><given-names>IA</given-names></name><name><surname>Konturek</surname><given-names>PC</given-names></name><name><surname>Koebnick</surname><given-names>C</given-names></name><etal/></person-group><year>2003</year><article-title>Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment</article-title><source>Eur Respir J</source><volume>22</volume><fpage>251</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">12952256</pub-id></citation></ref><ref id="b75-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hatipoglu</surname><given-names>U</given-names></name><name><surname>Rubinstein</surname><given-names>I</given-names></name></person-group><year>2003</year><article-title>Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis</article-title><source>Respiration</source><volume>70</volume><fpage>665</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">14732803</pub-id></citation></ref><ref id="b76-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawrylkiewicz</surname><given-names>I</given-names></name><name><surname>Sliwinski</surname><given-names>P</given-names></name><name><surname>Gorecka</surname><given-names>D</given-names></name><etal/></person-group><year>2004</year><article-title>Pulmonary haemody-namics in patients with OSAS or an overlap syndrome</article-title><source>Monaldi Arch Chest Dis</source><volume>61</volume><fpage>148</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">15679007</pub-id></citation></ref><ref id="b77-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>PL</given-names></name></person-group><year>2005</year><article-title>The role of behavioral sleep medicine in the assessment and treatment of sleep disordered breathing</article-title><source>Clin Psychol Rev</source><volume>25</volume><fpage>673</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">15951084</pub-id></citation></ref><ref id="b78-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heijdra</surname><given-names>YF</given-names></name><name><surname>Dekhuijzen</surname><given-names>PN</given-names></name><name><surname>van Herwaarden</surname><given-names>CL</given-names></name><etal/></person-group><year>1995</year><article-title>Nocturnal saturation and respiratory muscle function in patients with chronic obstructive pulmonary disease</article-title><source>Thorax</source><volume>50</volume><fpage>610</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">7638800</pub-id></citation></ref><ref id="b79-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hudgel</surname><given-names>DW</given-names></name><name><surname>Devadatta</surname><given-names>P</given-names></name></person-group><year>1984</year><article-title>Decrease in functional residual capacity during sleep in normal humans</article-title><source>J Appl Physiol</source><volume>57</volume><fpage>1319</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">6520027</pub-id></citation></ref><ref id="b80-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hudgel</surname><given-names>DW</given-names></name><name><surname>Gordon</surname><given-names>EA</given-names></name><name><surname>Thanakitcharu</surname><given-names>S</given-names></name><etal/></person-group><year>1998</year><article-title>Instability of ventilatory control in patients with obstructive sleep apnea</article-title><source>Am J Respir Crit Care Med</source><volume>158</volume><fpage>1142</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9769273</pub-id></citation></ref><ref id="b81-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hudgel</surname><given-names>DW</given-names></name></person-group><year>1992</year><article-title>Mechanisms of obstructive sleep apnea</article-title><source>Chest</source><volume>101</volume><fpage>541</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1735286</pub-id></citation></ref><ref id="b82-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imagawa</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Ogawa</surname><given-names>K</given-names></name><etal/></person-group><year>2004</year><article-title>Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome</article-title><source>Respiration</source><volume>71</volume><fpage>24</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">14872107</pub-id></citation></ref><ref id="b83-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname><given-names>MS</given-names></name><name><surname>Lam</surname><given-names>KS</given-names></name><name><surname>Ho</surname><given-names>C</given-names></name><etal/></person-group><year>2000</year><article-title>Serum leptin and vascular risk factors in obstructive sleep apnea</article-title><source>Chest</source><volume>118</volume><fpage>580</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10988175</pub-id></citation></ref><ref id="b84-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ip</surname><given-names>MS</given-names></name><name><surname>Tse</surname><given-names>HF</given-names></name><name><surname>Lam</surname><given-names>B</given-names></name><etal/></person-group><year>2004</year><article-title>Endothelial function in obstructive sleep apnea and response to treatment</article-title><source>Am J Respir Crit Care Med</source><volume>169</volume><fpage>348</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">14551167</pub-id></citation></ref><ref id="b85-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>R</given-names></name><name><surname>Chaouat</surname><given-names>A</given-names></name><name><surname>Weitzenblum</surname><given-names>E</given-names></name><etal/></person-group><year>1996</year><article-title>Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences</article-title><source>Eur Respir J</source><volume>9</volume><fpage>787</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">8726947</pub-id></citation></ref><ref id="b86-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kokturk</surname><given-names>O</given-names></name><name><surname>Ciftci</surname><given-names>TU</given-names></name><name><surname>Mollarecep</surname><given-names>E</given-names></name><etal/></person-group><year>2005</year><article-title>Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome</article-title><source>Int Heart J</source><volume>46</volume><fpage>801</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16272771</pub-id></citation></ref><ref id="b87-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krimsky</surname><given-names>WR</given-names></name><name><surname>Leiter</surname><given-names>JC</given-names></name></person-group><year>2005</year><article-title>Physiology of breathing and respiratory control during sleep</article-title><source>Semin Respir Crit Care Med</source><volume>26</volume><fpage>5</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">16052413</pub-id></citation></ref><ref id="b88-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kushida</surname><given-names>CA</given-names></name><name><surname>Littner</surname><given-names>MR</given-names></name><name><surname>Morgenthaler</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>Practice parameters for the indications for polysomnography and related procedures: an update for 2005</article-title><source>Sleep</source><volume>28</volume><fpage>499</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">16171294</pub-id></citation></ref><ref id="b89-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laks</surname><given-names>L</given-names></name><name><surname>Lehrhaft</surname><given-names>B</given-names></name><name><surname>Grunstein</surname><given-names>RR</given-names></name><etal/></person-group><year>1995</year><article-title>Pulmonary hypertension in obstructive sleep apnoea</article-title><source>Eur Respir J</source><volume>8</volume><fpage>537</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">7664850</pub-id></citation></ref><ref id="b90-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lattimore</surname><given-names>JL</given-names></name><name><surname>Wilcox</surname><given-names>I</given-names></name><name><surname>Skilton</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation</article-title><source>Thorax</source><volume>61</volume><fpage>491</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16537671</pub-id></citation></ref><ref id="b91-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leech</surname><given-names>JA</given-names></name><name><surname>Onal</surname><given-names>E</given-names></name><name><surname>Baer</surname><given-names>P</given-names></name><etal/></person-group><year>1987</year><article-title>Determinants of hypercapnia in occlusive sleep apnea syndrome</article-title><source>Chest</source><volume>92</volume><fpage>807</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">3117499</pub-id></citation></ref><ref id="b92-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>CA</given-names></name><name><surname>Eaton</surname><given-names>TE</given-names></name><name><surname>Fergusson</surname><given-names>W</given-names></name><etal/></person-group><year>2003</year><article-title>Home overnight pulse oximetry in patients with COPD: more than one recording may be needed</article-title><source>Chest</source><volume>123</volume><fpage>1127</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">12684303</pub-id></citation></ref><ref id="b93-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liistro</surname><given-names>G</given-names></name></person-group><year>2002</year><article-title>Pathophysiology of upper airway obstruction during sleep</article-title><source>Acta Otorhinolaryngol Belg</source><volume>56</volume><fpage>101</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12092316</pub-id></citation></ref><ref id="b94-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CC</given-names></name></person-group><year>1994</year><article-title>Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome</article-title><source>Eur Respir J</source><volume>7</volume><fpage>2005</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">7875273</pub-id></citation></ref><ref id="b95-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindberg</surname><given-names>A</given-names></name><name><surname>Jonsson</surname><given-names>AC</given-names></name><name><surname>Ronmark</surname><given-names>E</given-names></name><etal/></person-group><year>2005</year><article-title>Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor&#x02019;s diagnosis, symptoms, age, gender, and smoking habits</article-title><source>Respiration</source><volume>72</volume><fpage>471</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16210885</pub-id></citation></ref><ref id="b96-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindstrom</surname><given-names>M</given-names></name><name><surname>Jonsson</surname><given-names>E</given-names></name><name><surname>Larsson</surname><given-names>K</given-names></name><etal/></person-group><year>2002</year><article-title>Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden</article-title><source>Int J Tuberc Lung Dis</source><volume>6</volume><fpage>76</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">11931405</pub-id></citation></ref><ref id="b97-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome</article-title><source>J Tongji Med Univ</source><volume>20</volume><fpage>200</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">11215046</pub-id></citation></ref><ref id="b98-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loube</surname><given-names>DI</given-names></name><name><surname>Loube</surname><given-names>AA</given-names></name><name><surname>Mitler</surname><given-names>MM</given-names></name></person-group><year>1994</year><article-title>Weight loss for obstructive sleep apnea: the optimal therapy for obese patients</article-title><source>J Am Diet Assoc</source><volume>94</volume><fpage>1291</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">7963174</pub-id></citation></ref><ref id="b99-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Louw</surname><given-names>SJ</given-names></name><name><surname>Goldin</surname><given-names>JG</given-names></name><name><surname>Joubert</surname><given-names>G</given-names></name></person-group><year>1996</year><article-title>Spirometry of healthy adult South African men. Part I. Normative values</article-title><source>S Afr Med J</source><volume>86</volume><fpage>814</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8764907</pub-id></citation></ref><ref id="b100-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lugaresi</surname><given-names>E</given-names></name><name><surname>Coccagna</surname><given-names>G</given-names></name><name><surname>Mantovani</surname><given-names>M</given-names></name><etal/></person-group><year>1972</year><article-title>Some periodic phenomena arising during drowsiness and sleep in man</article-title><source>Electroencephalogr Clin Neurophysiol</source><volume>32</volume><fpage>701</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">4121520</pub-id></citation></ref><ref id="b101-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>GC</given-names></name><name><surname>Champman</surname><given-names>KR</given-names></name><name><surname>Ali</surname><given-names>SH</given-names></name><etal/></person-group><year>1996</year><article-title>Sleep quality and nocturnal respiratory function with once-daily theophylline (Uniphyl) and inhaled salbutamol in patients with COPD</article-title><source>Chest</source><volume>110</volume><fpage>648</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">8797406</pub-id></citation></ref><ref id="b102-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Man</surname><given-names>SF</given-names></name><name><surname>Connett</surname><given-names>JE</given-names></name><name><surname>Anthonisen</surname><given-names>NR</given-names></name><etal/></person-group><year>2006</year><article-title>C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease</article-title><source>Thorax</source><volume>61</volume><fpage>849</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">16738034</pub-id></citation></ref><ref id="b103-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mansfield</surname><given-names>D</given-names></name><name><surname>Naughton</surname><given-names>MT</given-names></name></person-group><year>1999</year><article-title>Effects of continuous positive airway pressure on lung function in patients with chronic obstructive pulmonary disease and sleep disordered breathing</article-title><source>Respirology</source><volume>4</volume><fpage>365</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">10612570</pub-id></citation></ref><ref id="b104-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>JM</given-names></name><name><surname>Carrizo</surname><given-names>SJ</given-names></name><name><surname>Vicente</surname><given-names>E</given-names></name><etal/></person-group><year>2005</year><article-title>Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study</article-title><source>Lancet</source><volume>365</volume><fpage>1046</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15781100</pub-id></citation></ref><ref id="b105-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>NS</given-names></name><name><surname>Barnes</surname><given-names>M</given-names></name><name><surname>Travier</surname><given-names>N</given-names></name><etal/></person-group><year>2006</year><article-title>Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis</article-title><source>Thorax</source><volume>61</volume><fpage>430</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">16467072</pub-id></citation></ref><ref id="b106-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>RJ</given-names></name><name><surname>Bartelson</surname><given-names>BL</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name><etal/></person-group><year>1999</year><article-title>Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD</article-title><source>Chest</source><volume>115</volume><fpage>1338</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">10334150</pub-id></citation></ref><ref id="b107-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McKeon</surname><given-names>JL</given-names></name><name><surname>Murree-Allen</surname><given-names>K</given-names></name><name><surname>Saunders</surname><given-names>NA</given-names></name></person-group><year>1989</year><article-title>Supplemental oxygen and quality of sleep in patients with chronic obstructive lung disease</article-title><source>Thorax</source><volume>44</volume><fpage>184</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2650011</pub-id></citation></ref><ref id="b108-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McNicholas</surname><given-names>WT</given-names></name><name><surname>Calverley</surname><given-names>PM</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><etal/></person-group><year>2004</year><article-title>Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD</article-title><source>Eur Respir J</source><volume>23</volume><fpage>825</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">15218993</pub-id></citation></ref><ref id="b109-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Millman</surname><given-names>RP</given-names></name><name><surname>Knight</surname><given-names>H</given-names></name><name><surname>Kline</surname><given-names>LR</given-names></name><etal/></person-group><year>1988</year><article-title>Changes in compartmental ventilation in association with eye movements during REM sleep</article-title><source>J Appl Physiol</source><volume>65</volume><fpage>1196</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">3182489</pub-id></citation></ref><ref id="b110-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minoguchi</surname><given-names>K</given-names></name><name><surname>Tazaki</surname><given-names>T</given-names></name><name><surname>Yokoe</surname><given-names>T</given-names></name><etal/></person-group><year>2004</year><article-title>Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome</article-title><source>Chest</source><volume>126</volume><fpage>1473</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15539715</pub-id></citation></ref><ref id="b111-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morrell</surname><given-names>MJ</given-names></name><name><surname>Harty</surname><given-names>HR</given-names></name><name><surname>Adams</surname><given-names>L</given-names></name><etal/></person-group><year>1995</year><article-title>Changes in total pulmonary resistance and PCO2 between wakefulness and sleep in normal human subjects</article-title><source>J Appl Physiol</source><volume>78</volume><fpage>1339</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">7615441</pub-id></citation></ref><ref id="b112-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>NL</given-names></name><name><surname>Francis</surname><given-names>PW</given-names></name><name><surname>Gurwitz</surname><given-names>D</given-names></name><etal/></person-group><year>1980</year><article-title>Mechanism of hemoglobin desaturation during rapid-eye-movement sleep in normal subjects and in patients with cystic fibrosis</article-title><source>Am Rev Respir Dis</source><volume>121</volume><fpage>463</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7416580</pub-id></citation></ref><ref id="b113-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulloy</surname><given-names>E</given-names></name><name><surname>McNicholas</surname><given-names>WT</given-names></name></person-group><year>1996</year><article-title>Ventilation and gas exchange during sleep and exercise in severe COPD</article-title><source>Chest</source><volume>109</volume><fpage>387</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">8620710</pub-id></citation></ref><ref id="b114-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nieto</surname><given-names>FJ</given-names></name><name><surname>Herrington</surname><given-names>DM</given-names></name><name><surname>Redline</surname><given-names>S</given-names></name><etal/></person-group><year>2004</year><article-title>Sleep apnea and markers of vascular endothelial function in a large community sample of older adults</article-title><source>Am J Respir Crit Care Med</source><volume>169</volume><fpage>354</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">14551166</pub-id></citation></ref><ref id="b115-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nieto</surname><given-names>FJ</given-names></name><name><surname>Young</surname><given-names>TB</given-names></name><name><surname>Lind</surname><given-names>BK</given-names></name><etal/></person-group><year>2000</year><article-title>Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study</article-title><source>JAMA</source><volume>283</volume><fpage>1829</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">10770144</pub-id></citation></ref><ref id="b116-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Brien</surname><given-names>A</given-names></name><name><surname>Whitman</surname><given-names>K</given-names></name></person-group><year>2005</year><article-title>Lack of benefit of continuous positive airway pressure on lung function in patients with overlap syndrome</article-title><source>Lung</source><volume>183</volume><fpage>389</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">16465599</pub-id></citation></ref><ref id="b117-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oflaz</surname><given-names>H</given-names></name><name><surname>Cuhadaroglu</surname><given-names>C</given-names></name><name><surname>Pamukcu</surname><given-names>B</given-names></name><etal/></person-group><year>2006</year><article-title>Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension</article-title><source>Respiration</source><volume>73</volume><fpage>751</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">16804287</pub-id></citation></ref><ref id="b118-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohga</surname><given-names>E</given-names></name><name><surname>Nagase</surname><given-names>T</given-names></name><name><surname>Tomita</surname><given-names>T</given-names></name><etal/></person-group><year>1999</year><article-title>Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome</article-title><source>J Appl Physiol</source><volume>87</volume><fpage>10</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">10409552</pub-id></citation></ref><ref id="b119-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orr</surname><given-names>WC</given-names></name><name><surname>Shamma-Othman</surname><given-names>Z</given-names></name><name><surname>Levin</surname><given-names>D</given-names></name><etal/></person-group><year>1990</year><article-title>Persistent hypoxemia and excessive daytime sleepiness in chronic obstructive pulmonary disease (COPD)</article-title><source>Chest</source><volume>97</volume><fpage>583</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">2306962</pub-id></citation></ref><ref id="b120-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ozturk</surname><given-names>L</given-names></name><name><surname>Unal</surname><given-names>M</given-names></name><name><surname>Tamer</surname><given-names>L</given-names></name><etal/></person-group><year>2003</year><article-title>The association of the severity of obstructive sleep apnea with plasma leptin levels</article-title><source>Arch Otolaryngol Head Neck Surg</source><volume>129</volume><fpage>538</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">12759266</pub-id></citation></ref><ref id="b121-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>SR</given-names></name><name><surname>White</surname><given-names>DP</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><etal/></person-group><year>2003</year><article-title>Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis</article-title><source>Arch Intern Med</source><volume>163</volume><fpage>565</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">12622603</pub-id></citation></ref><ref id="b122-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pauwels</surname><given-names>RA</given-names></name><name><surname>Buist</surname><given-names>AS</given-names></name><name><surname>Ma</surname><given-names>P</given-names></name><etal/></person-group><year>2001</year><article-title>Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary</article-title><source>Respir Care</source><volume>46</volume><fpage>798</fpage><lpage>825</lpage><pub-id pub-id-type="pmid">11463370</pub-id></citation></ref><ref id="b123-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peker</surname><given-names>Y</given-names></name><name><surname>Hedner</surname><given-names>J</given-names></name><name><surname>Norum</surname><given-names>J</given-names></name><etal/></person-group><year>2002</year><article-title>Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up</article-title><source>Am J Respir Crit Care Med</source><volume>166</volume><fpage>159</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">12119227</pub-id></citation></ref><ref id="b124-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pe&#x000f1;a</surname><given-names>VS</given-names></name><name><surname>Miravitlles</surname><given-names>M</given-names></name><name><surname>Gabriel</surname><given-names>R</given-names></name><etal/></person-group><year>2000</year><article-title>Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study</article-title><source>Chest</source><volume>118</volume><fpage>981</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11035667</pub-id></citation></ref><ref id="b125-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phillipson</surname><given-names>EA</given-names></name></person-group><year>1978</year><article-title>Control of breathing during sleep</article-title><source>Am Rev Respir Dis</source><volume>118</volume><fpage>909</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">216294</pub-id></citation></ref><ref id="b126-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pichel</surname><given-names>F</given-names></name><name><surname>Zamarron</surname><given-names>C</given-names></name><name><surname>Magan</surname><given-names>F</given-names></name><etal/></person-group><year>2004</year><article-title>Health-related quality of life in patients with obstructive sleep apnea: effects of long-term positive airway pressure treatment</article-title><source>Respir Med</source><volume>98</volume><fpage>968</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">15481273</pub-id></citation></ref><ref id="b127-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinto-Plata</surname><given-names>VM</given-names></name><name><surname>Mullerova</surname><given-names>H</given-names></name><name><surname>Toso</surname><given-names>JF</given-names></name><etal/></person-group><year>2006</year><article-title>C-reactive protein in patients with COPD, control smokers and non-smokers</article-title><source>Thorax</source><volume>61</volume><fpage>23</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16143583</pub-id></citation></ref><ref id="b128-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radwan</surname><given-names>L</given-names></name><name><surname>Maszczyk</surname><given-names>Z</given-names></name><name><surname>Koziorowski</surname><given-names>A</given-names></name><etal/></person-group><year>1995</year><article-title>Control of breathing in obstructive sleep apnoea and in patients with the overlap syndrome</article-title><source>Eur Respir J</source><volume>8</volume><fpage>542</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">7664851</pub-id></citation></ref><ref id="b129-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramsey</surname><given-names>SD</given-names></name><name><surname>Sullivan</surname><given-names>SD</given-names></name></person-group><year>2003</year><article-title>The burden of illness and economic evaluation for COPD</article-title><source>Eur Respir J Suppl</source><volume>41</volume><fpage>29</fpage><lpage>35</lpage></citation></ref><ref id="b130-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Kirchner</surname><given-names>HL</given-names></name><name><surname>Quan</surname><given-names>SF</given-names></name><etal/></person-group><year>2004</year><article-title>The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture</article-title><source>Arch Intern Med</source><volume>164</volume><fpage>406</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">14980992</pub-id></citation></ref><ref id="b131-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Leitner</surname><given-names>J</given-names></name><name><surname>Arnold</surname><given-names>J</given-names></name><etal/></person-group><year>1997</year><article-title>Ventilatory-control abnormalities in familial sleep apnea</article-title><source>Am J Respir Crit Care Med</source><volume>156</volume><fpage>155</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">9230740</pub-id></citation></ref><ref id="b132-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redline</surname><given-names>S</given-names></name><name><surname>Strohl</surname><given-names>KP</given-names></name></person-group><year>1998</year><article-title>Recognition and consequences of obstructive sleep apnea hypopnea syndrome</article-title><source>Clin Chest Med</source><volume>19</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">9554214</pub-id></citation></ref><ref id="b133-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Resta</surname><given-names>O</given-names></name><name><surname>Foschino-Barbaro</surname><given-names>MP</given-names></name><name><surname>Bonfitto</surname><given-names>P</given-names></name><etal/></person-group><year>2000</year><article-title>Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea</article-title><source>Respir Med</source><volume>94</volume><fpage>240</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10783935</pub-id></citation></ref><ref id="b134-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Grundy</surname><given-names>SM</given-names></name></person-group><year>2004</year><article-title>Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?</article-title><source>Circulation</source><volume>109</volume><fpage>2818</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">15197153</pub-id></citation></ref><ref id="b135-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>R</given-names></name></person-group><year>1999</year><article-title>Atherosclerosis--an inflammatory disease</article-title><source>N Engl J Med</source><volume>340</volume><fpage>115</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">9887164</pub-id></citation></ref><ref id="b136-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rutter</surname><given-names>MK</given-names></name><name><surname>Meigs</surname><given-names>JB</given-names></name><name><surname>Sullivan</surname><given-names>LM</given-names></name><etal/></person-group><year>2004</year><article-title>C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study</article-title><source>Circulation</source><volume>110</volume><fpage>380</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15262834</pub-id></citation></ref><ref id="b137-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saaresranta</surname><given-names>T</given-names></name><name><surname>Irjala</surname><given-names>K</given-names></name><name><surname>Aittokallio</surname><given-names>T</given-names></name><etal/></person-group><year>2005</year><article-title>Sleep quality, daytime sleepiness and fasting insulin levels in women with chronic obstructive pulmonary disease</article-title><source>Respir Med</source><volume>99</volume><fpage>856</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">15939247</pub-id></citation></ref><ref id="b138-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sajkov</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Saunders</surname><given-names>NA</given-names></name><etal/></person-group><year>1999</year><article-title>Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease</article-title><source>Am J Respir Crit Care Med</source><volume>159</volume><fpage>1518</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">10228120</pub-id></citation></ref><ref id="b139-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sampol</surname><given-names>G</given-names></name><name><surname>Sagales</surname><given-names>MT</given-names></name><name><surname>Roca</surname><given-names>A</given-names></name><etal/></person-group><year>1996</year><article-title>Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease</article-title><source>Eur Respir J</source><volume>9</volume><fpage>111</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">8834343</pub-id></citation></ref><ref id="b140-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sandek</surname><given-names>K</given-names></name><name><surname>Andersson</surname><given-names>T</given-names></name><name><surname>Bratel</surname><given-names>T</given-names></name><etal/></person-group><year>1999</year><article-title>Sleep quality, carbon dioxide responsiveness and hypoxaemic patterns in nocturnal hypoxaemia due to chronic obstructive pulmonary disease (COPD) without daytime hypoxaemia</article-title><source>Respir Med</source><volume>93</volume><fpage>79</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">10464857</pub-id></citation></ref><ref id="b141-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>MH</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name><name><surname>Haggerty</surname><given-names>CL</given-names></name><etal/></person-group><year>2003</year><article-title>Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease</article-title><source>Am J Respir Crit Care Med</source><volume>167</volume><fpage>7</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">12502472</pub-id></citation></ref><ref id="b142-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanner</surname><given-names>BM</given-names></name><name><surname>Doberauer</surname><given-names>C</given-names></name><name><surname>Konermann</surname><given-names>M</given-names></name><etal/></person-group><year>1997</year><article-title>Pulmonary hypertension in patients with obstructive sleep apnea syndrome</article-title><source>Arch Intern Med</source><volume>157</volume><fpage>2483</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9385300</pub-id></citation></ref><ref id="b143-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schols</surname><given-names>AM</given-names></name><name><surname>Creutzberg</surname><given-names>EC</given-names></name><name><surname>Buurman</surname><given-names>WA</given-names></name><etal/></person-group><year>1999</year><article-title>Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease</article-title><source>Am J Respir Crit Care Med</source><volume>160</volume><fpage>1220</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10508810</pub-id></citation></ref><ref id="b144-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seneviratne</surname><given-names>U</given-names></name><name><surname>Puvanendran</surname><given-names>K</given-names></name></person-group><year>2004</year><article-title>Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors</article-title><source>Sleep Med</source><volume>5</volume><fpage>339</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">15222989</pub-id></citation></ref><ref id="b145-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Series</surname><given-names>F</given-names></name><name><surname>Cormier</surname><given-names>Y</given-names></name><name><surname>Desmeules</surname><given-names>M</given-names></name><etal/></person-group><year>1989</year><article-title>Effects of respiratory drive on upper airways in sleep apnea patients and normal subjects</article-title><source>J Appl Physiol</source><volume>67</volume><fpage>973</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2507508</pub-id></citation></ref><ref id="b146-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shamsuzzaman</surname><given-names>AS</given-names></name><name><surname>Winnicki</surname><given-names>M</given-names></name><name><surname>Lanfranchi</surname><given-names>P</given-names></name><etal/></person-group><year>2002</year><article-title>Elevated C-reactive protein in patients with obstructive sleep apnea</article-title><source>Circulation</source><volume>105</volume><fpage>2462</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12034649</pub-id></citation></ref><ref id="b147-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Chin</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><etal/></person-group><year>2002</year><article-title>Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome</article-title><source>Thorax</source><volume>57</volume><fpage>429</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">11978920</pub-id></citation></ref><ref id="b148-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simonds</surname><given-names>AK</given-names></name><name><surname>Parker</surname><given-names>RA</given-names></name><name><surname>Branthwaite</surname><given-names>MA</given-names></name></person-group><year>1989</year><article-title>The effect of intermittent positive-pressure hyperinflation in restrictive chest wall disease</article-title><source>Respiration</source><volume>55</volume><fpage>136</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">2682863</pub-id></citation></ref><ref id="b149-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sin</surname><given-names>DD</given-names></name><name><surname>Man</surname><given-names>SF</given-names></name></person-group><year>2003</year><article-title>Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease</article-title><source>Circulation</source><volume>107</volume><fpage>1514</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">12654609</pub-id></citation></ref><ref id="b150-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Somers</surname><given-names>VK</given-names></name><name><surname>Mark</surname><given-names>AL</given-names></name><name><surname>Abboud</surname><given-names>FM</given-names></name></person-group><year>1988</year><article-title>Sympathetic activation by hypoxia and hypercapnia--implications for sleep apnea</article-title><source>Clin Exp Hypertens A</source><volume>10</volume><fpage>413</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">3072127</pub-id></citation></ref><ref id="b151-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soto Campos</surname><given-names>JG</given-names></name><name><surname>Cano</surname><given-names>GS</given-names></name><name><surname>Fernandez</surname><given-names>GJ</given-names></name><etal/></person-group><year>1996</year><article-title>Hypercapnic stimulation and ventilation response in the syndrome of sleep obstructive apnea. Comparison of reinhalation and steady state</article-title><source>Arch Bronconeumol</source><volume>32</volume><fpage>341</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8963513</pub-id></citation></ref><ref id="b152-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steens</surname><given-names>RD</given-names></name><name><surname>Pouliot</surname><given-names>Z</given-names></name><name><surname>Millar</surname><given-names>TW</given-names></name><etal/></person-group><year>1993</year><article-title>Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease</article-title><source>Sleep</source><volume>16</volume><fpage>318</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">8341892</pub-id></citation></ref><ref id="b153-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takabatake</surname><given-names>N</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>S</given-names></name><etal/></person-group><year>2000</year><article-title>The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease</article-title><source>Am J Respir Crit Care Med</source><volume>161</volume><fpage>1179</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">10764309</pub-id></citation></ref><ref id="b154-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tangel</surname><given-names>DJ</given-names></name><name><surname>Mezzanotte</surname><given-names>WS</given-names></name><name><surname>Sandberg</surname><given-names>EJ</given-names></name><etal/></person-group><year>1992</year><article-title>Influences of NREM sleep on the activity of tonic vs inspiratory phasic muscles in normal men</article-title><source>J Appl Physiol</source><volume>73</volume><fpage>1058</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">1400018</pub-id></citation></ref><ref id="b155-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tatsumi</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>H</given-names></name><name><surname>Kunitomo</surname><given-names>F</given-names></name><etal/></person-group><year>1986</year><article-title>Sleep arterial oxygen desaturation and chemical control of breathing during wakefulness in COPD</article-title><source>Chest</source><volume>90</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">3720388</pub-id></citation></ref><ref id="b156-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weitzenblum</surname><given-names>E</given-names></name><name><surname>Chaouat</surname><given-names>A</given-names></name></person-group><year>2004</year><article-title>Sleep and chronic obstructive pulmonary disease</article-title><source>Sleep Med Rev</source><volume>8</volume><fpage>281</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">15233956</pub-id></citation></ref><ref id="b157-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wellman</surname><given-names>A</given-names></name><name><surname>Jordan</surname><given-names>AS</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><etal/></person-group><year>2004</year><article-title>Ventilatory control and airway anatomy in obstructive sleep apnea</article-title><source>Am J Respir Crit Care Med</source><volume>170</volume><fpage>1225</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">15317668</pub-id></citation></ref><ref id="b158-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>DP</given-names></name><name><surname>Weil</surname><given-names>JV</given-names></name><name><surname>Zwillich</surname><given-names>CW</given-names></name></person-group><year>1985</year><article-title>Metabolic rate and breathing during sleep</article-title><source>J Appl Physio</source><volume>59</volume><fpage>384</fpage><lpage>91</lpage></citation></ref><ref id="b159-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whitelaw</surname><given-names>WA</given-names></name><name><surname>Brant</surname><given-names>RF</given-names></name><name><surname>Flemons</surname><given-names>WW</given-names></name></person-group><year>2005</year><article-title>Clinical usefulness of home oximetry compared with polysomnography for assessment of sleep apnea</article-title><source>Am J Respir Crit Care Med</source><volume>171</volume><fpage>188</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">15486338</pub-id></citation></ref><ref id="b160-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiegand</surname><given-names>DA</given-names></name><name><surname>Latz</surname><given-names>B</given-names></name><name><surname>Zwillich</surname><given-names>CW</given-names></name><etal/></person-group><year>1990</year><article-title>Geniohyoid muscle activity in normal men during wakefulness and sleep</article-title><source>J Appl Physiol</source><volume>69</volume><fpage>1262</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2262443</pub-id></citation></ref><ref id="b161-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiegand</surname><given-names>L</given-names></name><name><surname>Zwillich</surname><given-names>CW</given-names></name><name><surname>Wiegand</surname><given-names>D</given-names></name><etal/></person-group><year>1991</year><article-title>Changes in upper airway muscle activation and ventilation during phasic REM sleep in normal men</article-title><source>J Appl Physiol</source><volume>71</volume><fpage>488</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">1938720</pub-id></citation></ref><ref id="b162-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiegand</surname><given-names>L</given-names></name><name><surname>Zwillich</surname><given-names>CW</given-names></name></person-group><year>1994</year><article-title>Obstructive sleep apnea</article-title><source>Dis Mon</source><volume>40</volume><fpage>197</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">8143553</pub-id></citation></ref><ref id="b163-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiegand</surname><given-names>L</given-names></name></person-group><year>1990</year><article-title>Sleep and resistive loading influences on human upper airway collapsibility</article-title><source>Prog Clin Biol Res</source><volume>345</volume><fpage>157</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">2377632</pub-id></citation></ref><ref id="b164-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wijkstra</surname><given-names>PJ</given-names></name><name><surname>Lacasse</surname><given-names>Y</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name><etal/></person-group><year>2003</year><article-title>A meta-analysis of nocturnal noninvasive positive pressure ventilation in patients with stable COPD</article-title><source>Chest</source><volume>124</volume><fpage>337</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">12853542</pub-id></citation></ref><ref id="b165-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>JL</given-names></name><name><surname>Levy</surname><given-names>RD</given-names></name><name><surname>Churg</surname><given-names>A</given-names></name></person-group><year>2005</year><article-title>Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment</article-title><source>Thorax</source><volume>60</volume><fpage>605</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15994270</pub-id></citation></ref><ref id="b166-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yende</surname><given-names>S</given-names></name><name><surname>Waterer</surname><given-names>GW</given-names></name><name><surname>Tolley</surname><given-names>EA</given-names></name><etal/></person-group><year>2006</year><article-title>Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects</article-title><source>Thorax</source><volume>61</volume><fpage>10</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16284220</pub-id></citation></ref><ref id="b167-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yokoe</surname><given-names>T</given-names></name><name><surname>Minoguchi</surname><given-names>K</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><etal/></person-group><year>2003</year><article-title>Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure</article-title><source>Circulation</source><volume>107</volume><fpage>1129</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">12615790</pub-id></citation></ref><ref id="b168-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Younes</surname><given-names>M</given-names></name><name><surname>Ostrowski</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>W</given-names></name><etal/></person-group><year>2001</year><article-title>Chemical control stability in patients with obstructive sleep apnea</article-title><source>Am J Respir Crit Care Med</source><volume>163</volume><fpage>1181</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">11316657</pub-id></citation></ref><ref id="b169-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>T</given-names></name><name><surname>Palta</surname><given-names>M</given-names></name><name><surname>Dempsey</surname><given-names>J</given-names></name><etal/></person-group><year>1993</year><article-title>The occurrence of sleep-disordered breathing among middle-aged adults</article-title><source>N Engl J Med</source><volume>328</volume><fpage>1230</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8464434</pub-id></citation></ref><ref id="b170-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zamarron</surname><given-names>C</given-names></name><name><surname>Gude</surname><given-names>F</given-names></name><name><surname>Barcala</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>Utility of oxygen saturation and heart rate spectral analysis obtained from pulse oximetric recordings in the diagnosis of sleep apnea syndrome</article-title><source>Chest</source><volume>123</volume><fpage>1567</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">12740275</pub-id></citation></ref><ref id="b171-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zamarron</surname><given-names>C</given-names></name><name><surname>Gude</surname><given-names>F</given-names></name><name><surname>Otero</surname><given-names>Y</given-names></name><etal/></person-group><year>1998</year><article-title>Symptoms of sleep apnea syndrome in the general population</article-title><source>Arch Bronconeumol</source><volume>34</volume><fpage>245</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9656063</pub-id></citation></ref><ref id="b172-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zamarron</surname><given-names>C</given-names></name><name><surname>Gude</surname><given-names>F</given-names></name><name><surname>Otero</surname><given-names>Y</given-names></name><etal/></person-group><year>1999</year><article-title>Prevalence of sleep disordered breathing and sleep apnea in 50- to 70-year-old individuals. A survey</article-title><source>Respiration</source><volume>66</volume><fpage>317</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">10461079</pub-id></citation></ref><ref id="b173-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zamarron-Sanz</surname><given-names>C</given-names></name><name><surname>Ricoy-Galbaldon</surname><given-names>J</given-names></name><name><surname>Gude-Sampedro</surname><given-names>F</given-names></name><etal/></person-group><year>2006</year><article-title>Plasma levels of vascular endothelial markers in obstructive sleep apnea</article-title><source>Arch Med Res</source><volume>37</volume><fpage>552</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16624658</pub-id></citation></ref><ref id="b174-copd-3-671"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zouaoui</surname><given-names>BK</given-names></name><name><surname>Van</surname><given-names>MA</given-names></name><name><surname>Doumit</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity C-reactive protein elevation</article-title><source>Respiration</source><volume>73</volume><fpage>243</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16549947</pub-id></citation></ref></ref-list></back><floats-wrap><fig id="f1-copd-3-671" position="float"><label>Figure 1</label><caption><p>A heuristic model of the complex associations between sleep, COPD and sleep apnea.</p><p><bold>Abbreviations:</bold> COPD, chronic obstructive pulmonary disease; OSAS, obstructive sleep apnea syndrome.</p></caption><graphic xlink:href="copd-3-671f1"/></fig><fig id="f2-copd-3-671" position="float"><label>Figure 2</label><caption><p>Simultaneous recording of nocturnal oximetry and heart rate in a patient with COPD.</p><p><bold>Abbreviation:</bold> COPD, chronic obstructive pulmonary disease.</p></caption><graphic xlink:href="copd-3-671f2"/></fig><table-wrap id="t1-copd-3-671" position="float"><label>Table 1</label><caption><p>COPD desaturation characteristics</p></caption><table frame="hsides" rules="none"><tbody><tr><td align="left" rowspan="1" colspan="1">Occurs mainly during REM sleep</td></tr><tr><td align="left" rowspan="1" colspan="1">Presents considerable variability in nocturnal desaturation from night to night</td></tr><tr><td align="left" rowspan="1" colspan="1">Statistically relationships exist between nocturnal desaturation and daytime hypoxemia and hypercarbia</td></tr><tr><td align="left" rowspan="1" colspan="1">Nocturnal desaturarion cannot be predicted from awake measurement of arterial oxygen saturation in individual patients</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-copd-3-671"><p><bold>Abbreviations:</bold> COPD, chronic obstructive pulmonary disease; REM, rapid eye movement sleep.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t2-copd-3-671" position="float"><label>Table 2</label><caption><p>Prevalence of overlap syndrome in COPD and OSAS patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Authors</th><th align="left" rowspan="1" colspan="1">Number of patients</th><th align="left" rowspan="1" colspan="1">Sample</th><th align="left" rowspan="1" colspan="1">Group</th><th align="left" rowspan="1" colspan="1">Prevalence</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Chaouat</td><td align="left" rowspan="1" colspan="1">265</td><td align="left" rowspan="1" colspan="1">Sleep Laboratory</td><td align="left" rowspan="1" colspan="1">OSAS</td><td align="left" rowspan="1" colspan="1">11%</td></tr><tr><td align="left" rowspan="1" colspan="1">Resta</td><td align="left" rowspan="1" colspan="1">213</td><td align="left" rowspan="1" colspan="1">Sleep Laboratory</td><td align="left" rowspan="1" colspan="1">OSAS</td><td align="left" rowspan="1" colspan="1">13.6%</td></tr><tr><td align="left" rowspan="1" colspan="1">De Miguel</td><td align="left" rowspan="1" colspan="1">193</td><td align="left" rowspan="1" colspan="1">Sleep Laboratory</td><td align="left" rowspan="1" colspan="1">OSAS</td><td align="left" rowspan="1" colspan="1">28.5%</td></tr><tr><td align="left" rowspan="1" colspan="1">Sanders</td><td align="left" rowspan="1" colspan="1">1132</td><td align="left" rowspan="1" colspan="1">General population</td><td align="left" rowspan="1" colspan="1">COPD</td><td align="left" rowspan="1" colspan="1">14%</td></tr><tr><td align="left" rowspan="1" colspan="1">Zamarr&#x000f3;n</td><td align="left" rowspan="1" colspan="1">300</td><td align="left" rowspan="1" colspan="1">Sleep Laboratory</td><td align="left" rowspan="1" colspan="1">OSAS</td><td align="left" rowspan="1" colspan="1">15.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">Bednarek</td><td align="left" rowspan="1" colspan="1">676</td><td align="left" rowspan="1" colspan="1">General population</td><td align="left" rowspan="1" colspan="1">OSAS</td><td align="left" rowspan="1" colspan="1">9.2%</td></tr><tr><td align="left" rowspan="1" colspan="1">O&#x02019;Brien</td><td align="left" rowspan="1" colspan="1">120</td><td align="left" rowspan="1" colspan="1">Sleep Laboratory</td><td align="left" rowspan="1" colspan="1">OSAS</td><td align="left" rowspan="1" colspan="1">11.9%</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-copd-3-671"><p><bold>Abbreviations:</bold> COPD, chronic obstructive pulmonary disease; OSAS, obstructive sleep apnea syndrome.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article>